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ABSTRACT 
Evaluating the Effectiveness of Supervision on Trauma Training Outcomes for Assertive 
Community Treatment Teams 
by 
Sacha Zilkha 
 
Adviser: Denise Hien, Ph.D. 
 
 Most individuals receiving mental health care do not have access to evidence-based 
psychological treatments, regardless of psychological disorder.  Despite the development of 
effective evidence based treatments and available clinical training, clinician uptake and 
adherence to such treatments has been low. In this study, the effectiveness of a trauma treatment 
training model was evaluated through a quasi-experimental design to better inform and address 
the gap between the existence of evidence based care and lack of evidence based treatment 
options available in the community. Specifically, data from 23 Assertive Community Treatment 
Teams in New York City that underwent a 1-day ICBT training along with 12-month data 
collection with optional added supervision was analyzed to determine the benefits of added 
supervision. Of the 23 teams, 12 opted for added supervision (i.e., Master Training). Results 
indicate a potential benefit of supervisory calls on increasing the number of ICBT sessions 
provided. However, teams that had added supervision did not have better clinical outcomes on 
average when compared to teams that did not have the added supervision. Keywords: cognitive 
behavior therapy; posttraumatic stress disorder; implementation; dissemination; Assertive 
Community Treatment 
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Chapter 1: Introduction to the Study 
Background 
 Despite the availability of evidence-based psychological treatment modalities, most 
individuals receiving mental health care in the public sector do not have access to evidence-
based psychological care, regardless of psychological disorder. (Barlow, Bullis, Comer, & 
Ametaj, 2013; Drake and Essock, 2009; Herschell, Kolko, Baumann, & Davis, 2010).  For 
therapists who work with individuals with complex co-occurring needs, such as co-occurring 
Serious Mental Illness (SMI), Post-Traumatic Stress Disorder (PTSD) and Substance Use 
Disorder (SUD), targeted interventions are particularly important because individuals with co-
occurring needs have worse outcomes than individuals with singular disorders and have been 
historically underserved (Fuller, 2010; McGovern et al., 2011; Mueser, Noorsday, Drake, & Fox, 
2003). At the same time, many therapists in community-based settings don’t feel equipped to 
treat individuals with such complex needs because of inadequate training and experience 
(McGovern, Lambert-Harris, Alterman, Xie, & Meier, 2011). To better prepare clinicians in 
public mental health settings who often see individuals with complex co-occurring needs, it 
seems that more focused training and workforce development needs to take place in order to help 
community-based clinicians learn how to effectively apply evidence-based psychological 
interventions. 
 One way to help clinicians learn new and efficacious practices is through training and 
workforce development. However, research indicates that training in Evidence-Based Practices 
(EBPs) alone does not lead to the actual implementation of the practices taught (Beidas, 
Edmunds, Marcus & Kendall, 2012; Herschell et al., 2010; Kolko et al., 2012; Procotor, et al., 
2009). Rather, multi-pronged approaches that incorporate on-going learning have been shown to 
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be more effective than training alone (Beidas et al., 2012). For example, supervision is one 
critically important component that has started to show promise in terms of increasing treatment 
adherence and competence among clinicians. However, research in this area is limited and the 
use of supervision as part of community based training models needs to be further researched.  
 The following study was designed to evaluate the effectiveness of supervision on training 
outcomes for Assertive Community Treatment (ACT) Teams. Specifically ACT Teams were 
trained to use a specific type of Cognitive Behavioral Therapy (CBT) for individuals with 
Serious Mental Illness (SMI), and co-occurring PTSD and SUD. This treatment, Integrated CBT 
for PTSD and SUD has been found to be effective based on the research literature and the 
following study aimed to evaluate the role of supervision and other variables on the frequency 
with which ACT Teams used ICBT post-training and with supervisory supports. As such, this 
study explored issues pertaining to sustainable training and supervision of evidence based 
treatment implementation including workforce development and related clinical outcomes within 
a special population to create increased access to EBPs in the community. Specifically, a plan 
was developed that evaluated supervision as a predictor of treatment implementation among 
community based mental health providers trained in ICBT. 
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Chapter 2: Literature Review 
Research to Practice Gap 
 Over the past fifteen years, increased attention has been given to what is commonly 
referred to as the research to practice gap in the behavioral health field; the existence of 
efficacious mental health practices in the literature compared to the use of unstandardized 
psychosocial treatments offered in community settings (Hogan, 2003). Though there is growing 
evidence that certain psychosocial treatments are efficacious and effective at treating certain 
disorders, most individuals are not receiving evidence-based care in community mental health 
settings (Barlow et al., 2013). While this is an issue for the behavioral health field, it is not 
unique to human services. Motivating and initiating change within any context brings challenges 
(Rogers, 2003). While there has been an abundance of evidence-based treatments developed over 
the years, the research to practice gap has become more and more evident in the behavioral 
health sector.  
 Successfully bringing “human service technologies” (e.g., Evidence Based Practices 
[EBPs]) into standard practice is more complex than other types of technologies (Aarons, et al., 
2010). In the healthcare sector, original research may take up to seventeen years to yield patient 
benefits (Balas, 2000). For example, in some outpatient settings, research has found that less than 
ten percent of individuals with schizophrenia receive evidence based psychosocial treatments 
despite the existence of such treatments (Torrey et al., 2001). Another example of the research to 
practice gap is seen in the treatment of individuals with Co-Occurring Mental Health and 
Substance Use Disorders (COD). Despite over fifteen years of research showing that individuals 
with COD benefit most from treatment that simultaneously addresses their mental health and 
substance use needs, in 2008, only seven percent of individuals with COD received treatment 
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that addressed both disorders (Substance Abuse and Mental Health Administration [SAMHSA], 
2008 & 2009). Again, this has been seen very recently in the availability for evidence based 
services for individuals with first episode psychoses. While early intervention is a key approach 
and EBPs exist to improve prognosis, there is much smaller availability of early psychosis 
programs offering EBPs than the problem demands (Csillag et al., 2015). 
 While one may imagine that clinicians would want to provide the best treatments available 
to those they serve, there are many reasons why there is such a large research practice gap. One 
of the biggest challenges to closing the gap is that clinical research does not always match 
clinical practice. Nonetheless evidence based practice research has moved swiftly over the last 
ten years. SAMHSA’s National Registry for Evidence-based Programs and Practices (NREPP) 
lists 330 interventions for a variety of mental health and substance use disorders (SAMHSA, 
2014). Despite the large array of treatments to choose from however, they do not necessarily 
match the needs of the community. While clinicians tend to be inclined to want to match 
treatments to individual patients based on an amalgamation of needs, most evidence based 
treatments are symptom specific and have taken place in laboratory settings, often leaving out 
patients who have multiply occurring needs (Kazdin, 2008). This disconnect, thus, leaves 
clinicians feeling skeptical as their patients differ from those being treated in the lab. And with 
the hundreds of treatments to choose from in the context of an overworked and often underpaid 
workforce, it is no wonder that clinicians have little motivation to seek out evidence-based 
treatments for the individuals they serve.  
 Despite healthy skepticism that emerges from singular clinical trials that may not always 
reflect the clinical populations served by practitioners, skepticism also abounds when research is 
less insular, which is the case for EBPs. EBPs, unlike Empirically Supported Treatments (ESTs) 
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bring together the best research and practice evidence in the field to inform clinical approaches 
to care. EBPs in effect provide approaches to clinical work that includes research, clinical 
expertise and client preferences (Lilienfeld et al., 2013). Thus EBPs are less insular, are based on 
various studies and include clinical expertise and client preferences in a comprehensive and 
meaningful way. ESTs on the other hand, are treatments that have shown themselves to be 
efficacious based on two research studies where they must outperform a pill or other treatment 
(Chambless & Hollon, 1998). As such, EBPs are more generalizable and better suited to the 
more complex clinical needs that better represent individuals in treatment. Yet, practitioners are 
still hesitant to support such practices or treatments that have been shown to be effective across 
varying patient populations (Lilienfeld et al., 2013). Specifically, clinicians seem to conflate 
EBPs with ESTs and cite reasons against ESTs when explaining resistance toward EBPs 
generally (Lilienfeld, et al., 2013).  
 Since many EBPs have been manualized and in turn become a sort of EBP-based EST, 
clinicians often report concerns providing treatments that seem overly mechanized, and fear that 
such treatments will detract from building a healthy therapeutic alliance (Freuh, Gurbaugh, 
Cusak & Elhai, 2010). These concerns, while valid, lead to resistance in learning new therapeutic 
techniques. While the “dodo bird” effect has shown that when ESTs or EBPs are pitted against 
each other, for the most part, no significant differences arise (Luborsky et al., 2002).  For mental 
health clinicians with master’s and bachelor’s levels of education these treatments that have a 
research base are extremely important in bolstering clinical acumen and provide a way for non-
doctoral level clinicians to practice effective forms of treatment.  
 Despite continuous psychotherapy research and innovations in the field, most clinicians 
place a higher premium on clinical interactions with patients and learning from colleagues than 
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scientific evidence in part due to unfounded fears related to EBPs (Stewart & Chambless, 2007). 
In addition to the confusion between EBPs and ESTs clinicians often rely on naïve realism, or 
the idea that what they perceive is in fact reality. In this way, clinicians stick strongly to the 
belief that what they do works (Lilienfeld, et al., 2013). However, solely relying on individual 
perceptions of patient progress is not an effective means by which to evaluate treatment 
effectiveness.  For example, it is a common misconception among treatment providers who 
provide clinical services to individuals with SMI that the individuals they see are too sick or 
uneducated to benefit from a manualized approach, while research shows otherwise (Gaag, 
2014). At the same time, research shows that clinicians cannot effectively determine patient 
progress or predict patient decline as well as the kinds of objective evidence used in treatment 
outcome studies (Lambert et al., 2002). In fact clinicians tend to rate themselves more highly in 
their patients’ clinical outcomes than is the case based on objective outcome measures (Lambert 
et al., 2002).  
Translational Science 
 To address the many barriers to bringing research into practice, researchers have begun to 
focus on translation; ways of translating clinical research into clinical practice. While the basic 
concept of translation has been around for at least forty years (Wolf, 1974), it is only now 
becoming a major focus in the health sciences (Drolet & Lorenzi, 2011). In the mental health 
sector, translational science aims to speed up the time lag between research and practice by 
breaking research down into easily understood clinical practices. Translational science is 
biphasic. The first phase involves testing basic science (e.g., an EST) in community applicable 
ways such as through the use of effectiveness studies that include community mental health 
patients and practitioners. The second phase involves researching the best ways to bring EBPs 
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into the community (Brekke, Ell, & Palinkas, 2007). Together, these phases ensure that clinical 
research can be brought into the community in the most effective ways possible, leading to the 
greatest patient gains. However, despite, these efforts, clinicians continue to provide treatment 
that is based on clinical acumen and what is familiar over scientific evidence (Lilienfeld et al., 
2013).  
 While phase one efforts have effectively translated basic science into clinical practice and 
easy to use interventions, less attention has been paid to phase two efforts directed at 
implementing these practice among community practitioners (Drolet & Lorenzi, 2011). For 
example, phase two efforts typically only receive one percent of the funding that phase one 
efforts receive despite their necessity (Tetroe et al., 2008). Phase two efforts are essential 
because they take the burden of translating science into practice off clinicians who are already 
skeptical, overwhelmed and unlikely to be motivated to implement a new practice without seeing 
how it would work with their patients. Thus, without effective phase two efforts clinicians have 
limited motivation to adopt EBPs while patient groups and families don’t have access to the 
evidence-based care that they need (Eccles et al., 2009).  
Intervention Model 
 According to the National Institute of Health ([NIH] 2014), a stage-based model of clinical 
intervention development is thought to best develop and bring research into practice (Onken, 
Carroll, Shoham, Cuthbert & Riddle, 2014). The model put forth by NIH starts with “Stage 0,” 
which includes an understanding of the “basic science” needed behind the development of any 
potentially meaningful intervention. The next stage, “Stage 1” includes the development of the 
intervention or refinement of a standing intervention to prepare it for “Stage 2,” which includes 
testing the efficacy of the intervention via a clinical trial. Once the intervention has passed the 
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“efficacy” test, it needs to move on to “Stage 3” before it can be brought to the public. “Stage 3” 
involves testing the efficacy of the intervention in the community via a well-controlled study in a 
community clinic. This stage is followed by “Stage 4,” which includes testing the intervention 
for effectiveness in the community in ways that emulate reality (i.e., without the strict controls of 
an efficacy study). Once effectiveness is established, “Stage 5” involves finding ways to 
implements and disseminate the practice into community settings.  
 NIH’s model cautions researchers and practitioners about skipping stages so as to ensure 
the intervention will best be taken up and understood in the community. Specifically, the model 
warns against moving from efficacy studies to dissemination and implementation before the 
research is adequately translated into community practice and found to be effective. NIH posits 
that “the work is not complete until an intervention reaches its highest level of potency and is 
implementable with the maximum number of people in the population for which it was 
developed” (Onken, et al., 2014 p. 27). Thus, highlighting the importance of translational 
research in addition to the actual dissemination and implementation of an intervention into  
community-based settings. 
Dissemination and Implementation Research 
 While efforts to bring research into practice through dissemination and implementation 
have received less attention than efforts to translate research into clinical practices, finding 
effective ways to bring and maintain empirically supported interventions into community 
settings has been gaining traction over the last ten years (e.g., Beidas et al; Proctor et al., 2009; 
Proctor et al., 2011; Torrey et al., 2012).  Efforts to effectively bring a new intervention to a 
community involves the dissemination and implementation of a that intervention, with 
dissemination and implementation often being talked about as one in the same. However, 
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dissemination specifically refers to the communication of a new practice while implementation 
involves the methods by which health care innovations most effectively take place and can be 
sustained over time at policy, organizational and clinical levels (Proctor, Powell, & McMillen, 
2013).  
 The term “implementation science,” which implies that it is the study of implementation, 
typically also involves a dissemination component and is sometimes also referred to as 
“dissemination & implementation (D&I) research” (Tabak, Khoong, Chambers & Brownson, 
2012). Together, dissemination and implementation theories provide guidance to public health 
advocates and government entities that wish to increase the use of EBPs among community 
mental health providers through clinician adoption and implementation of these practices over 
time. This area of research has become so important that some have proposed a ten year stop to 
efficacy research in favor of determining the most effective and fastest ways to bring research to 
practice (Kessler & Glasgow, 2011). 
Dissemination and Implementation Theory 
 While early research on EBP implementation neglected theory in the selection of 
dissemination and/or implementation strategies (Davier, Walker & Grimshaw, 2010; Eccles et 
al., 2005; French et al., 2012; Michie et al.; 2005; Stelk, 2006; etc.), more recent studies have 
both used and outlined some of the more basic theories behind EBP dissemination and 
implementation (Dingfelder & Mandell, 2012; May, 2013; Tabak et al.,, 2012).  Among 
implementation scientists, efforts are being made to better incorporate and test organizational 
and psychological theories that can help researchers select and test implementation strategies 
(French et al., 2012). Theories behind D&I research help frame and bring context to 
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dissemination and implementation strategies improving their likelihood to succeed (Tabak et al., 
2012). 
 Everett Rogers’ (2003) Diffusion of Innovations theory is one of the more popular theories 
that is drawn upon in D&I research (Dingfelder & Mandell, 2012; Gotham, 2004; Stelk 2006; 
Rohrbach et al., 1993). According to Rogers (2003), diffusion or dissemination is the process 
used to communicate an innovative practice within a community over time. This process 
involves “the innovation, communication channels, time and the social system” (Rogers, 2005 p. 
33). In terms of EBP implementation, the social system would encompass a group or groups of 
behavioral health providers, the EBP would be the innovation or new technology introduced to 
providers, the communication channels would be the means by which and the individuals 
involved in informing and educating those mental health providers of a selected EBP, and the 
time involved and the rate at which an innovation is adopted would be measured by the number 
of providers who adopt an EBP in a selected time period.  
 Building upon Rogers’ theory, Rohrbach (1993) and Dingfelder and Mandell (2012) 
suggest that that the process of diffusion is continuous and typically includes four main stages: 
dissemination, adoption, implementation and maintenance (Dingfelder & Mandell, 2012). The 
dissemination stage involves the strategies needed to increase potential adopters’ awareness of 
the innovation and obtain their buy in. The adoption stage is the point at which the system 
commits to trying out the innovation. The implementation stage marks the time during which 
individuals in the social system begin to use the innovation. And the maintenance stage begins 
once the innovation moves from something new that is being tested out to becoming part of 
community’s standard practice.   
 Each stage in the diffusion process is impacted by a variety of factors. The perception of 
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the innovation accounts for the greatest variance in terms of whether an innovation will become 
part of the system and stay a part of the system overtime (Rogers, 2003). Thus, the way in which 
an innovation is packaged and sold is very important. According to Rogers (2003), and those 
who have tested his theory, three attributes are of particular importance when trying to introduce 
an innovation. These include the innovations’ complexity, compatibility and relative advantage 
(Dingfelder & Mandell, 2012). Thus, the easier an innovation appears to be, its capacity to easily 
fold into already existing practices and its benefits to the individual or community greatly 
determine whether the innovation will be adopted.  
 While Rogers laid out his theory of diffusion over forty years ago, only recently have we 
developed a better understanding of this and other theories as they relate to EBP implementation 
(Proctor et al., 2009). As D&I research studies have gained traction so has our knowledge of 
what is and isn’t effective in terms of changing clinician behaviors. For many years individuals 
had little to go on beyond anecdotal information, case reports or controlled experiments with 
little external validity (Glasgow et al. 2006).  Yet, despite the lack of knowledge and the many 
challenges that exist bringing EBPs into community mental health settings, federal, state and 
local health departments have made EBP dissemination a priority. Despite evidence 
demonstrating the importance of implementation science, federal and local efforts have primarily 
focused on dissemination and the development of specialty training initiatives as opposed to 
ensuring the implementation of evidence-based practices in community mental health settings 
(Herschell et al., 2010; Barlow et al., 2013).  While the desire to increase the use of EBPs 
through direct training programs is understandable, focus on training alone may have been 
premature.  
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Clinical Training 
 Research now shows that training alone is not an effective means by which behavioral 
change takes place (Beidas, et al. 2012; Brunette et al., 2008; Joyce & Showers, 2002; Whitley, 
Gingerich, Lutz, & Mueser, 2009). Despite well-intentioned efforts, these finding may help 
explain why many clinicians still do not provide evidence-based support. Although training can 
increase clinicians’ knowledge about an evidence-based practice, it has not been shown to lead to 
clinicians incorporating what they have learned into their day-to-day work (e.g., Beidas et al., 
2012; Davis et al. 1999; Walters et al. 2005). In a study by Davis et al. (1999), that evaluated 
continuing medical education, Davis and colleagues found that didactic education sessions did 
not lead to behavior change and limited knowledge transfer, while interactive training, provided 
greater knowledge transfer but with limited overall gains. This trend is also true for behavioral 
health settings, even when training is coupled with a contractual mandate to provide EBPs, 
clinician behavior doesn’t change  (Lopez, Osterberg, Jensen-Doss, & Rae, 2011).  
 Most D&I researchers agree that implementation of an evidence based practice requires a 
variety of components (Torrey, Tepper and Greenwold et al., 2011; Sylavian & Lamothe, 2013). 
Some factors that have been shown to increase the likelihood that an evidence based practice will 
be implemented include strong “change” leaders who can manage and oversee implementation 
efforts at the program level; staff motivation and interest in the treatment modality; staff 
perception that change is needed; financial and administrative support; oversight that requires 
providers to track and report organizational and client level outcomes; continuous workforce 
development, which includes but is not limited to staff training in conjunction with strong 
clinical supervision and expert consultation; favorable attitudes toward EBPs; and management 
of staff turnover (Aarons et al., 2012; McGovern, Lambert-Harris, McHugo, Giard & Mangrum, 
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2010; Torrey et al., 2011; Sylvain & Lamothe, 2013). Thus, training efforts alone can no longer 
be used to ensure an EBP will become part of one’s clinical practice.    
Expert Consultation/Supervision and Implementation Research 
 While efforts have been made to include many of the aforementioned implementation 
variables within single studies – some of these variables are easier to control than others.  For an 
outside entity (e.g., government) mandating training or beginning to introduce an EBP, expert 
consultation and funding may be easier variables to control than staff motivation, internal 
supervision or internal oversight because expert consultation and funding can be controlled 
externally. Expert consultation is particularly easy for those implementing training to include in 
training plans granted funding is accessible. Expert consultation is typically provided by the 
individual or affiliated individuals conducting a training and can be sold as part of the full 
training package. In particular, if expert consultation involves clinical supervisors it has the 
benefit of helping to ensure clinical supervision on the training material is built into a program’s 
internal structure.  
 Since clinical supervision is commonly assumed to be part of standard practice, one may 
assume that in-house clinical supervision would take place post-training to promote the use of 
the training modality taught. However, post-training supervision has traditionally been 
unstandardized and left to mid-level managers who themselves are not experts and at times have 
not been trained on the EBP that was taught. As such, most clinicians do not have access to 
regular internal post-training supervision of what they have learned (Milne, 2010). Expert 
supervision or consultation provided by trainers or treatment developers, on the other hand, is 
usually standardized and ensures someone familiar with the specific treatment modality provides 
the supervision. This familiarity combined with structured supervision increases the likelihood 
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that supervision will lead to treatment implementation or ensure that clinical supervisors are 
equipped to supervise their staff (Bearman et al., 2013; Beidas et al., 2012; Milne, 2010).  
 Despite growing evidence that expert consultation and clinical supervision lead to 
increased treatment implementation, little research has been done pertaining to this type of 
supervision outside of highly controlled clinical studies with volunteer subjects or involving 
clinicians providing treatment as part of a separate evidence based treatment models 
(Sholomskas et al., 2005) and results have even been mixed. In a recent study by Torrey, Bond, 
McHugo and Swain (2012), an inverse relationship between supervision and implementation was 
found. Furthermore, research on implementation factors among evidence-based treatments for 
special populations is even less prevalent and little research has been done to determine the 
effects of training and supervision on clinical outcomes among individuals with complex co-
occurring disorders (Barlow et al., 2013; Proctor et al., 2011; Torrey et al., 2012). Millions of 
dollars are spent every year to train new staff and increase competence and therefore determining 
ways to support and sustain these initiatives is needed to avoid wasting money and to ensure that 
individuals in the community receive the care they need.  
 Proctor and colleagues (2011) suggested that more research is needed in this area to 
determine the extent to which supervision and other implementation supports benefit clinical 
practice. Specifically, few studies have measured client level outcomes as they relate to 
supervision within treatment implementation studies (Schoenwald, Mehta, Frazier & Shernoff, 
2013). Research does show supervision is particularly meaningful within the context of agency 
buy-in and workflow changes (Brunette et al., 2008; Rapp, Goscha, & Carlson, 2010). And it 
seems as though the key component by which supervision works is how it encourages increased 
clinical practice in the treatment modality taught. Thus, it is the increased attention paid to staff 
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and continued focus on the learned treatments by agency leadership and supervisors themselves 
that promotes the implementation of a model after training (Whitely et al., 2009). 
 Supervision provided by trainers or other experts is relatively easy for agencies funding 
trainings to provide and has been shown to increase the likelihood a treatment will be 
implemented post-training (Beidas et al., 2012; Beidas & Kendall, 2010; & Sholomskas et al., 
2005; Miller et al., 2004). One way that such supervision is provided involves the use of 
consultation calls, and research looking at this method of consultation has found promising 
results (Bearman et al., 2013; Beidas et al., 2012).  However, these tools have primarily been 
evaluated among youth treatment providers and have not been evaluated among ACT Teams, 
which are constantly on the go and already work within an evidence based frame. 
SMI, PTSD, SUD and the rationale for Evidence-Based Practices 
While there are many challenges and much is still unknown in terms of implementing 
evidence based practices in the community, for individuals with complex co-occurring needs, 
evidence-based care is extremely important (e.g., Fuller, 2010; McGovern et al., 2011; Mueser, 
Noordsy, Drake, & Fox, 2003; Mueser, et al., 2008). For individuals with SMI, who have co-
occurring PTSD, and SUD this is especially true because rates of trauma exposure among 
individuals with SMI are up to twelve times higher than the general population, PTSD is under 
diagnosed among people with SMI, clinicians rarely provide PTSD treatment or integrated SUD 
treatment to individuals with SMI and most importantly, untreated PTSD and SUD increase the 
burden of illness among individuals with SMI, (Fuller, 2010; Mueser et al., 2008; Mueser et al., 
2002; Mueser et al., 1998; Read, Hammersley, & Rudegeair, 2007; Switzer et al., 1999; Subica, 
Claypoole & Wylie, 2012; & O'Hare, Shen, & Sherrer, 2012). 
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Rates of trauma exposure and PTSD are much higher among individuals with SMI than 
in the general population (Mueser et al., 2008; O'Hare, Shen, & Sherrer, 2012). Being exposed to 
trauma in childhood nearly triples one’s chance of developing a psychotic disorder (Varese et al., 
2012). Yet, PTSD and trauma screening does not routinely take place in community mental 
health settings, where most individuals with SMI receive treatment, despite the availability of 
reliable and valid PTSD screening and assessment tools for individuals with SMI (Grubaugh, 
Elhai, Cusack, Well & Frueh, 2007). In one study conducted by Mueser and colleagues (1998) 
where forty-three percent of individuals with SMI receiving community mental health services 
met criteria for PTSD, only two percent of individuals had a PTSD diagnosis documented in 
their charts.  
For individuals with SMI, many of whom may display psychotic symptoms or have 
major life stressors (e.g., homelessness, recurrent hospitalizations, medical needs, etc.), clinicians 
often feel the need to address those more obvious needs first and throughout (Freuh et al., 2010). 
Thus, clinicians become blinded to the possibility of a PTSD diagnosis and ignore the need for 
PTSD treatment. This is further complicated by the fact that most clinicians in community 
mental health setting have not been trained to recognize, or detect trauma (Freuh et al., 2001). 
This is unfortunate, considering that many of the overt symptoms and life stressors that clinicians 
observe are likely related to untreated PTSD symptoms, which could be easily detected with the 
use of a simple screening tool (Cusack, Frueh & Brady, 2004; & Mueser, Rosenberg, Goodman 
& Trumbetta, 2002).  
Even if routine trauma screening and assessments take place, the behavioral health 
workforce is not equipped to provide evidence based trauma treatments due to lack of training 
and misconceptions about treating trauma among individuals with SMI (Frueh 2001; Freuh et al., 
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2010). Trauma treatments are not readily available in community mental health settings in part 
because of under diagnoses but also due to genuine fears that treating PTSD among individuals 
with SMI will lead to increased psychiatric symptoms despite evidence that proves otherwise 
(Mueser et al., 2008). This is further complicated and substantiated since most community 
mental health clinicians are trained to provide case management and respond to the core 
disorders associated with SMI (e.g., major depression, bipolar disorder, schizophrenia, etc.) and 
not trauma (Frueh 2001; Freuh et al., 2010). Many of these providers have traditionally seen their 
patients as fragile and prefer to provide medication management services to address overt 
symptoms over psychotherapy (Cusack, et al., 2007). Similarly, clinicians have not and still do 
not always think it makes sense or feel comfortable providing treatment to individuals with 
substance use needs for similar reasons despite evidence that individuals with COD respond best 
to treatments that integrate mental health and substance use needs (Mueser et al., 2003).  
Despite concerns of clinicians and inadequate training, lack of PTSD treatment is an issue 
because untreated PTSD among individuals with SMI leads to increased substance use, 
psychiatric symptoms, physical health problems, difficulty functioning; and psychiatric 
hospitalizations (Mueser et al., 2002; Mueser et al., 2004; Switzer et al., 1999; & Subica, 
Claypoole & Wylie, 2012). Individuals with trauma histories not only are prone to increased 
psychiatric symptoms and hospitalizations, but are more likely to have hypertentsion, obesity, 
and cardiovascular disease (McFarlane, 2010).  Thus, exacerbating the individual and societal 
burden of illness. Trauma exposure, and PTSD, in particular, is associated with some of the 
greatest amounts of healthcare use and costs when compared to the general population 
(Greenberg et al., 1999; Hidalgo & Davidson, 2000; Kessler, 2000). Thus, leaving PTSD 
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untreated not only negatively impacts care and the individual receiving treatment but the health 
care system at large (Freuh et al., 2010).  
Evidence Based Treatment for PTSD 
 Despite a lack of PTSD treatment available in the community, several treatment 
approaches have been shown to effectively treat PTSD. The American Psychiatric Association 
identifies exposure-based therapies, cognitive behavioral and cognitive restructuring therapies, 
Eye Movement Desensitization and Reprocessing (EMDR) and medication in their treatment 
guidelines for PTSD (APA, 2004). Of these treatments, exposure-based therapies, which 
gradually re-introduce the individual to his or her past trauma in a safe environment, have the 
strongest research base (Bomyea & Lang, 2012; Rothbaum, Meadows, Resick & Foy, 2000). 
However, despite, stronger evidence for treatments with exposure components, exposure 
therapies have not traditionally been accepted among clinicians or tested rigorously for certain 
patient groups, including individuals with psychosis, extreme emotions, co-occurring conditions 
and/or active substance use disorders (van Minnen, A., Harned, Zoellner, & Mills, 2012; & Foa, 
2007).  
 While the research base is strongest for exposure based treatments and recent studies 
have started to show promise using exposure-based treatments for individuals with psychosis 
(Freuh et al., 2009; van den Berg & van der Gaag, 2012; de Bont, van Minnen & de Jongh, 
2013), at the time of this study there had been no controlled studies for this population to show 
whether or not it is safe and/or effective (Mabey & Servellen, 2014). Furthermore, for 
individuals with psychosis and/or other serious mental health conditions, facing feared situations 
or memories has been thought to be too stressful for both clinicians and patients due to symptom 
exacerbation (Mueser et al. 2008). However, since this study took place, one study has found 
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prolonged exposure therapy safe and effective for this population (van den Berg et al., 2015). 
Nonetheless, despite these promising findings, clinicians are hesitant to treat trauma among 
individuals with SMI in general, exposure based treatments may be extremely difficult to sell 
clinicians to practice. Similarly, for individuals with substance use disorders there have been 
concerns about the use of exposure based treatments for this population in increasing substance 
use (Hien et al., 2004; McGovern et al., 2009; Foa 2007; etc) and evidence of high dropout rates 
(Brady, Dansky, Back, Foa & Carroll, 2001).  A few pilot studies and one controlled trial have 
shown promising results in terms of demonstrating patient safety, but treatment outcomes  have 
not consistently demonstrated patient benefits across studies (Brady, Dansky, Back, Foa, & 
Carroll, 2001; Foa et al., 2013; Najavits, & Johnson, 2014; Mills et al., 2012).  
While exposure based therapies have the strongest research base, implementing such 
treatments in community mental health settings is not yet indicated for individuals with SMI 
and/or SUD. There is, however, evidence that non-exposure based Cognitive Behavioral Therapy 
(CBT) is equally as effective as some exposure-based treatments (Monson, Rodriguez & Warner, 
2005). Furthermore, CBT for PTSD developed by Mueser and colleagues (2008) was developed 
specifically for individuals with SMI and has been found to be safe, effective and better than 
treatment as usual for individuals with SMI and PTSD (Mueser et al., 2008; & Mueser et al., 
2015)). CBT for PTSD focuses on the here and now by directly targeting PTSD symptoms 
through relaxation skill training and cognitive restructuring techniques that teach patients how to 
evaluate their thoughts to change their feelings and corresponding reactions to situations.  
Integrated CBT for PTSD and Addiction (ICBT) 
ICBT (McGovern et al., 2011) uses the basic components that make up CBT for PTSD 
(Mueser et al., 2008) but differs in that it  includes a component that addresses harmful substance 
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use. Like CBT for PTSD, ICBT is comprised by a variety of EBPs including motivational 
interviewing, mindful relaxation, psycho-education and cognitive restructuring. ICBT has found 
to be safe and effective among individuals in substance use treatment with a variety of severe co-
occurring mental health needs and is easy for clinicians and patients to use (McGovern et al., 
2011). Unlike the original CBT for PTSD, ICBT has the benefit of addressing harmful substance 
use, which is exacerbated by and extremely common among individuals with SMI and PTSD 
(Subica et al., 2012).  
SMI, PTSD and SUD and Assertive Community Treatment (ACT) 
ACT is a community treatment model made up of a team of social workers, psychiatrists, 
nurses, caseworkers and peers who provide treatment to patients in their homes on a two time 
weekly basis with a minimum of six visits per month for fifteen to forty five minutes at a time. 
The original ACT model was developed in the 1970s and originally called Training in 
Community Living (Stein & Test, 1980). In the original model and subsequently after being 
named ACT, the point of this form of treatment was to act as a hospital without walls, keeping 
individuals who were frequent users of psychiatric inpatient treatment in the community to 
reduce cost and promote community reintegration (Bond et al., 2001).  ACT has an extensive 
evidence-base demonstrating that it helps individuals stay out of the hospital, leads to stable 
housing and reduces psychiatric symptoms and improves life quality (Bond et al., 2001).  
ACT Teams are comprised by nurses, social workers, psychiatrists and peer counselors. 
Each team serves sixty-eight clients. Teams share caseloads, and as such all Team members treat 
all sixty-eight clients.  ACT is indicated and available to individuals with SMI who have 
previously had difficulty adhering to traditional treatment. To meet ACT eligibility criteria, the 
individual seeking or referred to ACT services needs to have a SMI and demonstrate a history of 
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treatment non-adherence and recent psychiatric hospitalizations (New York State Office of 
Mental Health, 2013). As such, PTSD and substance use disorder rates are likely to be higher 
among ACT patients than for individuals in traditional community mental health programs since 
research indicates that outcomes and treatment adherence are typically worse for individuals with 
co-occurring PTSD and SUD (Fuller, 2010; McGovern et al., 2011; Mueser et al., 2008). 
However, prior to this study, ACT Teams had not previously received any type of trauma 
training.  
Current Study 
 As part of a larger initiative focused on improving access to best practices for COD among 
recipients of New York City Department of Health and Mental Hygiene (DOHMH) contracted 
mental health programs, approximately 306 ACT Team workers across 43 ACT Teams were 
trained to use ICBT over a three-week period between April and May of 2013. To support the 
implementation of ICBT, follow-up supervision and consultation by experts was offered to all 
ACT Teams post-training. The initiative manipulated the amount of supervision and consultation 
received by teams in a quasi-experimental design. Specifically, Team supervisors were able to 
volunteer themselves or staff with supervisory capacity to participate in receiving on-going 
supervision and training support after the initial round of follow-up support and supervision was 
provided.  
Hypotheses 
 Based on the literature, a framework for training and supervising clinicians post-training in 
an EBP was developed. As outlined above, trainings alone don’t work and thus by including 
supervision and consultation into the training plan, provider implementation of ICBT was 
expected to be higher and patient outcomes were expected to be better when more supervision 
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was received. Specifically, it was hypothesized that ACT Teams that receive increased 
supervision and consultation would show greater use of ICBT and better patient outcomes than 
Teams with less supervision and consultation. It was hypothesized that ACT Teams that received 
additional support would be encouraged to provide ICBT more by being more comfortable 
providing it and as a result of their on-going exposure to it. Thus, those ACT Teams were 
expected to provide more adherent ICBT sessions than those Teams that received the standard 
training and supervision. With greater sessions that are more adherent, patient outcomes were 
also expected to be better in the group with more support.  
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Chapter 3: Research Method 
Method 
Participants  
 Forty-three New York City ACT Teams comprised by 350 clinical staff members were 
offered ICBT Training and post-training supervision as part of a DOHMH initiative to promote 
the use of trauma informed practices to individuals with SMI and CoD in NYC.  
 Of the 350 clinical staff members offered the training, 306 individuals across all forty-
four teams accepted the training offer and were trained between April and May of 2013. The 306 
clinical staff members included individuals from high school graduates to Doctoral level 
educational backgrounds. No data are available on the demographic makeup of these providers.   
 Approximately 157 clients across the 43 teams were identified with PTSD, SUD and SMI 
(See Figure 1 below for client characteristics from original ACT consumers screened). These 157 
individuals were tracked between May 2013 and April 2014 on a monthly basis to determine the 
number of ICBT sessions received, substance use severity and hospitalization utilization. In 
order to keep consumer data confidential and to decrease the data collection burden, no 
demographic data was collected for the individuals receiving ICBT. 
Study Design  
 This was a quasi-experimental design consisting of two groups, one group that received a 
standard Integrative CBT (ICBT) Training for PTSD and addiction with supervision versus 
another group that received the same ICBT training plus additional supervision and consultation 
(i.e., the Master Level Training). The two groups were formed on a volunteer basis whereby 
teams that received the Master Level Training volunteered for this additional support once the 
Master Training was offered. Teams in both groups reported monthly data on treatment 
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implementation and clinical outcomes (substance use, PTSD, Stage of Change, and psychiatric 
emergencies). All data were collected and analyzed at baseline and 3month, 6-month, 9-month 
and 12-month follow-up intervals.  
Design Specifics 
 Forty-three New York City ACT Team members were offered ICBT Training and post-
training supervision as part of a DOHMH initiative to promote the use of trauma informed 
practices to individuals with SMI and COD. Prior to the training all Team supervisors (n=43) 
were instructed to collect data on all enrolled consumers (n=2,924). Team supervisors met 
monthly at DOHMH as part of a standard ongoing ACT Team meeting. Teams were informed of 
the data collection procedures one month prior to the first training date at one of their monthly 
meetings. Supervisors were sent a data collection form along with a PTSD (PC-PTSD) and a 
SUD (CAGE-AID) screening tool with instructions. Supervisors were instructed to have their 
clinical staff screen all consumers prior to the first day of training in order to identify clients with 
both PTSD and SUD for the ICBT treatment. Of the possible 2,924 ACT clients, 2,082 
consumers were screened for PTSD and SUD (See Figure 1, for breakdown of client clinical 
characteristics).  
Figure 1. Pre-Study PTSD and Substance Use Screening Results  
 
23% SUD 
Only (N=479)  
 8% SUD and 
PTSD 
(N=157)  
6% PTSD Only 
(N=134) 
63%  
No PTSD and 
No SUD  
(N=1312) 
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 Clinical staff members were trained with their ACT Teams in groups of twenty-five to 
forty-four participants across three 1-day intensive ICBT Trainings to review the ICBT manual 
and learn how to implement the model. Each Team received two manuals and was charged to 
implement the model across those clients who met the criteria for PTSD and SUD based on the 
initial screening data. Teams were instructed to collect monthly data on those consumers who 
screened positive for both PTSD and SUD. Teams were instructed to use their first ICBT visit to 
fully assess those clients who screened positive for PTSD and SUD for PTSD using the PCL as 
the baseline measure for PTSD symptoms. Teams were also instructed to assess their clients 
SUD severity using the AUS (Alcohol Use Scale) and DUS (Drug Use Scale) during the first 
ICBT visit. During the initial training, the DOHMH training coordinator thoroughly explained 
the monthly data collection procedures and forms, which included space to report AUS, DUS 
and PCL scores. In addition, providers were asked to report on their clients’ Stage of Change and 
whether the client went to a psychiatric emergency room during the reporting month and whether 
the client was admitted to the hospital for psychiatric reasons that month. Finally, clinicians were 
asked to report the number of ICBT and non-ICBT sessions conducted for the reporting month to 
determine the degree to which providers were implementing ICBT. As part of the 1-day training, 
providers were trained on the use of the above mentioned outcome measures and assessment 
tools.  Clinical outcome data and number of ICBT sessions were collected monthly in a data file 
created by the Training Coordinator, with the first data submission that was due June 7, 2013.  
The data collection forms were used to track client and implementation outcomes over a 12-
month period.   
 Each team was contacted by the Training Coordinator to set-up 2 follow-up 90-minute 
supervisory phone calls as part of the standard ICBT training (i.e., what everyone receives). The 
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phone calls were provided individually to each team (i.e., there will be 86 phone calls across 43 
teams) and led by either the trainer or the treatment developer. The phone calls reviewed ICBT 
cases with the teams and provided supervision and technical assistance to ACT Team members.  
 Once all providers participated in their first of two follow-up phone calls, the Training 
Coordinator offered ACT Team Supervisors and staff with supervisory roles the opportunity to 
participate in a “Master Training” on a volunteer basis. The Master Training involved three 
additional supervisory phone calls led by the ICBT trainer and treatment developer. The Master 
Training involved 15 ACT Teams, with one person from each team on the call. The phone calls 
discussed ways in which to further support staff needs in terms of implementing ICBT in 
addition to providing technical assistance related to specific ICBT cases. Supervisors were going 
to be the only Team members offered the training but due to low response from supervisors and 
high response from clinical staff a provision was made to allow any staff member to participate 
as long as they had the opportunity to provide some level of ICBT supervision to their fellow 
Team members. This was done in order to promote clinical ICBT supervision across Teams with 
Master Trainers. 
 Teams were required to collect and report on monthly client and implementation level 
data for 12-months. Teams were then compared on the outcome measures by training status (i.e., 
whether the Team had a supervisor receive the Master Training) at baseline, 3-month, 6-month, 
9-month and the end of the 12-month intervals. The number of ICBT sessions in relation 
treatment outcomes was also be evaluated to determine if the number of ICBT sessions improved 
clinical outcomes.  
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Measures  
 For the initial PTSD screening, the PC-PTSD (Primary Care PTSD Scale) was used. 
The PC-PTSD is a 4-item scale originally developed for primary care sites and other medical 
settings. The screen asks 4 questions, which relate to the DSM-IV TR (APA, 2000) criteria of 
general distress, avoidance, hyper-arousal and re-experiencing symptoms of PTSD. Each 
questions is answered with a “yes” or a “no” and scores range from 0-4, with a score of 3 or 
above indicating probable PTSD. The PC-PTSD has excellent inter-rater reliability and good test 
retest reliability. In addition the measure has good diagnostic efficiency in primary care settings 
with a score of three yielding specificity of .87 and sensitivity of .78 and (Prins et al., 2003). 
Though this tool was meant to be used in a primary care setting, it was selected because of its 
ease of use and short length.  
 For the initial SUD screening, the CAGE-AID (Cut down, Annoyed, Guilty, Eye 
opener – Adapted to include Drugs) was used. The CAGE-AID was developed for the World 
Health Organization for substance use detection in medical settings. The original measure, the 
CAGE, only assessed for Alcohol but an adapted version of the tool, CAGE-AID, was created to 
include drugs. The CAGE-AID is a 4-item that asks questions, which relate to the DSM-IV TR 
(APA, 2000) criteria of Substance Abuse and Dependence. The CAGE-AID evaluates alcohol 
and/or drug use. Each questions is answered with a “yes” or a “no” and scores range from 0-4, 
with a score of 1 or above indicating possible SUD. The CAGE has good reliability and validity 
and has been validated in groups of individuals with SMI (Center for Substance Abuse 
Treatment, 2005). The CAGE-AID was selected because of its ease of use, short length and use 
among individuals with SMI.  
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 For individuals who screened positive for PTSD and SUD, PTSD symptoms were then  
assessed and tracked using the PCL (PTSD Check List). The PCL assess all seventeen PTSD 
symptoms listed in the DSM-IV TR using 17 corresponding self-report items. Each item is rated 
from 0-5 on symptom severity with “0” being “not at all” and “5” being “extremely.” Scores can 
range from 0 to 68. Scores 44 or higher indicate probable PTSD. The PCL has excellent test-
retest reliability, high internal consistency and correlates highly with other measures of PTSD 
(Weathers, Litz, Herman, Huska, & Keane, 1993). The PCL has been used reliably across groups 
with both SMI and SUD (McGovern et al., 2011). The PCL was selected because of its ease of 
use, relatively short length and use among individuals with SMI.  
 For individuals who screened positive for PTSD and SUD, substance use symptoms were 
assessed and tracked using the AUS (Alcohol Use Scale) and the DUS (Drug Use Scale).  The 
AUS and DUS are very simple, yet reliable measures of substance use, which use a 5-point 
clinician rated scale (from “no problem” to “extremely severe”) an individual’s use of alcohol 
(i.e., on the AUS) and/or drug (i.e., on the DUS), which correspond to DSM-IV TR criteria for 
substance abuse and dependence. The AUS and DUS have high sensitivity and specificity, and 
good inter-rater and test re-test reliability within groups of individuals with and without SMI.  
(Drake et al., 1998). The AUS and DUS were selected because they are easy for clinicians to use 
and because they have previously been used in groups of individuals with SMI.  
Interventions 
Integrated Cognitive Behavioral Therapy (ICBT) is a manualized treatment for PTSD 
and SUD developed at Dartmouth by Mark McGovern, PhD and colleagues (2010). ICBT was 
developed as an adaption of CBT for PTSD for individuals with SMI developed by Kim Mueser 
and colleagues at Dartmouth (2008). ICBT was adapted to include addiction treatment within the 
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context of PTSD and SMI. McGovern and colleagues’ (2010) ICBT manual outlines a skills-
based approach to treating PTSD with CBT. This model explains CBT for PTSD in a step-by-
step manner across 8 modules, to be conducted over 12-16 weekly sessions. The clinician 
manual includes a client workbook that provides the client with handouts and homework 
assignments to reinforce ICBT modules.  
Module 1 (Introduction to Treatment) outlines the therapy approach, goals and 
mutual expectations. In Module 2 (Crisis & Relapse prevention plan), the 
clinician and patient review early warning signs, coping strategies and social 
supports to manage substance use and/or relapse. Module 3 (Breathing 
Retraining) teaches the patient an anxiety reduction skill. Module 4 (PTSD: 
Primary symptoms) introduces the three PTSD criterion symptoms (Re-
experiencing, Avoidance, Hyper-arousal) and provides patient education and 
normalization. Module 5 (PTSD: Associated Symptoms) identifies common 
negative emotions and affects associated with PTSD (a. Fear and anxiety; b. 
Sadness and depression; c. Guilt and shame; and d. Anger) as well as the 
interpersonal consequences of PTSD. A significant portion of this module is 
devoted to examining the interplay between PTSD symptoms and substance use. 
The cognitive behavioral technique of cognitive restructuring is the focus of 
Module 6 (Cognitive Restructuring Part I) and Module 7 (Cognitive Restructuring 
Part II). Module 6 focuses on the basic framework of identifying stressful 
activating situations, beliefs/thoughts and consequences (emotional or 
behavioral). Module 7 builds upon this framework and skill development by 
including steps on disputing the belief (incorporating common styles of thinking 
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handouts) and generating alternative emotions or behaviors. The final module, 
Module 8 (Generalization training) is designed to bring closure to the therapy 
relationship, consolidate a plan for continued application of the skills, and 
consider further treatment options. (McGovern et al., 2011, p. 211-212). 
Master ICBT Training (Increased Supervision) was used as the main intervention to 
determine between group differences on clinical outcomes and ICBT implementation. 
The Master Level training involved additional support and training provided to 
approximately 22 team supervisors via phone consultation by the treatment developer 
(Mark McGovern) and/or the ICBT trainer. During the Master phone calls, the 
consultation provided included discussions on the ways in which supervisors could 
further support staff needs in terms of implementing ICBT in addition to providing 
technical assistance related to specific ICBT cases.  
Data Analysis 
Of the 41 ACT Teams trained in ICBT, 28 agreed to participate in the study. 
However, due to unreliability of the data from four teams, these data sets were removed 
from the analysis. Therefore, we analyzed data from 12 Master and 11 Non-Master 
programs. 107 patients were represented across the 23 teams with 56 patients receiving 
services on Master Teams and 51 patients receiving services from Non-Master Teams.  
Data were analyzed using SPSS (17) (SPSS, 2008). Due to the data being non-parametric 
and because our small sample size was too small to meet the necessary power for statistical tests 
of significance, only descriptive statistics and effect sizes were used to analyze the data. 
Descriptive statistics were analyzed to determine the average number of ICBT sessions provided 
by Teams with without Master Level Clinicians during each month of the project. Effect sizes 
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evaluated the strength of the differences between Master and Non-Master Team outcomes. 
Furthermore, we used SPSS to generate treatment outcome data for each of these groups, which 
included differences in AUS, DUS and PCL scores by number of ICBT sessions received.   
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Chapter 4: Results 
Results 
Initial Training Information 
Each ACT Team participated in an initial ICBT training on 1 day between April and May 
of 2013. 9 out of 12 Master teams received their initial 1-day ICBT training at the end of April 
and 4 out of the 12 Master teams received their initial 1-day ICBT training early in May. For 
Non-Master Teams, 4 of the 11 teams received their training at the end of April and 7 of 11 
teams received their training in early May. As a way to capture all participant data during the 
time the ACT Teams received their initial ICBT training, the first reporting period during which 
ACT Teams reported ICBT data spanned five weeks (April 24, 2013 to May 31, 2014). All other 
reporting periods were 1 month long. As such, the first data period carried a bias in favor of 
teams that participated in their one day training earlier in the reporting period since there was 
more time for teams trained earlier to use their ICBT skills.  
During the first reporting period, 1 of the Master Teams received their initial ICBT 
supervisory call while none of the Non-Master Teams received an initial supervisory call. During 
the second reporting period, 4 Master and 3 Non-Master Teams received their initial ICBT calls. 
During the 3
rd
 reporting period, 7 Master and 7 Non-Master Teams received their first 
supervisory call. During the fourth reporting period 3 Master Teams received their second 
supervisory call while 1 Non-Master Team took part in its first call. By the fifth reporting period, 
4 Master and 4 Non-Master Teams took part in their second supervisory calls. During the 6
th
 
reporting period 4 Master and 6 Non-Master teams participated in their second supervisory call. 
During the 7
th
 reporting period 1 Master and 1 Non-Master Team took part in their second 
supervisory call. By the 8
th
 reporting period all teams had participated in their two supervisory 
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calls. During the 8
th
 reporting period the first two sets of Master calls took place with all Master 
Teams attending at least one Master Call. See Figure 1 for visual representation of when 
supervisory calls took place. 20 Master Teams participated in the first 2 Master Calls with 8 
teams participating in both calls, one team missing 2 calls and 2 teams missing 1 call. During 
period 9 the last Master call took place with 11 teams participating and 1 team missing the call.  
ACT Team Characteristics 
The composition of all ACT Teams across NYC is required to meet certain State 
requirements. This composition, thus ensures, similar levels of staff education and training 
across all teams. The main difference between ACT Teams and other outpatient clinical care 
services is that ACT Teams have a higher staff to consumer ratio, due to the severity of mental 
health symptoms required to receive ACT services. All ACT Teams are required to have at least 
1 clinical staff member for every 9 consumers and each position on the team must meet specific 
education and experience requirements. Therefore, teams have very similar characteristics in 
terms of staff level of experience and education, in addition to the number of staff members on 
each team. Similarly, each team is comprised by 68 consumers, with only very rare occasions 
that a team is not at their full consumer capacity.  Upon further analysis, there were no noticeable 
differences in staffing pattern between Master and Non-Master teams. Demographic data were 
requested from teams but due to a less than 50% response rate, this data have been excluded. 
However, when looking at Master Teams alone, and more specifically the individuals who 
participated in the calls, 9 of the 12 Master clinicians were early career clinicians while, 3 of the 
12 clinicians were Team Leaders (individuals with more experience in leadership positions). 
Anecdotally, two of the most active ICBT Master clinicians, left their ACT Teams for better 
career opportunities toward the end of the study.  
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There was one main difference between Master and Non-Master Teams in terms of 
patient characteristics that we were able to find. Specifically, Master Teams had fewer Assisted 
Outpatient (AOT) consumers on their entire caseload compared to Non-Master Teams during the 
month prior to teams signing up for the Master training. AOT consumers are mandated to 
treatment by the court and ACT teams are thus responsible for providing those individuals with 
more in-depth care and submitting weekly reports to the City of New York – thus leading to an 
increased workload. Furthermore, individuals on AOT are thought to have more severe mental 
health and substance use needs, thus giving the appearance that they require more attention. For 
Master Teams, 19.2% (N=10) of all of the consumers in the data reported had an AOT court 
order, while 25% (N=13) of all Non-Master Team consumers reported in the data had an AOT 
court order (See Figure 2 below).  
 
Figure 2. Percent AOT Clients on Master Versus Non-Master Status Teams 
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Initial Consumer Characteristics 
Patient AUS, DUS and Stage of Change scores were collected each month by a team 
assigned ACT Team member. AUS and DUS scores ranged from 1 to 5 with 1=Abstinence; 
2=Use without Impairment; 3= Abuse; 4= Dependence and 5 = Severe Dependence. Stage of 
Change Scores also ranged from 1 to 5 with 1= Pre-contemplation; 2 = Contemplation; 3 = 
Preparation; 4 = Action; and 5 = Maintenance. See Table 1 for a display of the following initial 
consumer characteristics.  
 
Table 1 Initial Consumer Characteristics by Master Team  
Master 
Status 
Average AUS 
Score 
Average DUS 
Score 
Average Stage of 
Change 
% with at 
least 1 
ER Visit  
% with at 
least 1 
Admission  
 
Master 
Teams 
(N=12) 
 
1.9  
(SD=.932) 
2.51  
(SD= 1.45) 
2.59  
(SD= 1.44) 
11%  
(SD=.32) 
11% 
(SD= .32) 
Non-Master 
Teams 
(N=11) 
2.4  
(SD=1.27) 
2.19 (SD= 1.31) 2.35  
(SD=1.45) 
20%  
(SD=.4) 
15% 
(SD=.36) 
 
The average AUS Score for consumers on Master Teams was 1.90 (SD=.932) during the 
first reporting period while the average AUS score for Non-Master Teams was 2.4 (SD= 1.27). 
The average DUS score for Master Teams was 2.51 (SD= 1.45) and for Non-Master teams the 
average DUS score was 2.19 (SD= 1.31). The average Stage of Change score was 2.59 (SD= 
1.44) for Master Teams and 2.35 (SD=1.45) for Non-Master Teams.  
During the first reporting period and throughout teams reported on whether or not 
consumers went to the ER or the hospital for psychiatric reasons during each reporting period. 
During the first reporting period, an average of .11 (SD= .32) consumers went to the hospital on 
at least one occasion from Master Teams and an average of .15 (SD=.36) consumers went to the 
hospital on at least one occasion on Non-Master Teams. For Master Teams an average of .11 
(SD=.32) individuals went to the ER at least one time and an average of .2 (SD=.4) individuals 
went to the ER at least one time on Non-Master Teams during the first reporting period.  
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ICBT Session Data 
Overall, Master Teams provided an average of 55.58 ICBT sessions (SD=26.19) during 
the 12 months of the study while Non-Master Teams provided an average of 30.81 ICBT 
sessions (SD=17.59). A summary of the average number of ICBT sessions across each of the 12 
months of the study for Master and Non-Master Teams is in Table 2 below and a breakdown 
comparing Master and Non-Master Teams on ICBT sessions provided is in Figure 3 below.  
Table 2 ICBT Session Data (standard deviation in parenthesis) 
 
Reporting  
Month 
Avg ICBT 
Sessions 
Master Teams 
(SD) 
Number of 
Mater Teams 
Participating 
in Supervisory 
Calls  
Avg ICBT 
Sessions for 
Non-Master 
Teams (SD) 
Number of Non-
Master Teams 
Participating in 
Supervisory Calls 
Avg 
Difference 
in ICBT 
Sessions  
 
Month 1 
 
3.00 (2.45) 
 
1 
 
1.36 (1.50) 
 
0 
 
1.64 
Month 2 3.50 (2.15) 4 3.36 (2.69) 3 .14 
Month 3 5.25 (2.67) 7 2.91 (2.34) 7 2.34 
Month 4 4.33 (3.03) 3 2.27 (2.76) 1 2.06 
Month 5 4.92 (1.73) 4 2.45 (2.34) 4 2.47 
Month 6 5.58 (4.25) 4 3.18 (2.79) 6 2.4 
Month 7 5.5 (4.76) 1 3.55 (3.21) 1 1.95 
Month 8* 5.92 (4.99) 23 2.91 (3.27) 0 3.01 
Month 9* 4.92 (3.55) 13 2.64 (2.66) 0 2.28 
Month 10 4.67 (3.14) 0 2.27 (1.68) 0 2.4 
Month 11 4.00 (3.02) 0 1.73(1.56) 0 2.27 
Month 12  3.92 (2.68) 0 2.18 (1.88) 0 1.74 
Total 55.58 (26.19) --- 30.18 (27.70) --- 24.7 
*Months during which Master calls took place 
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Figure 3. Master vs. Non-Master Teams on ICBT Session Frequency  
 
The mean difference between the average number of ICBT sessions provided by Master 
and Non-Master Teams was found to be large (Cohen’s d=1.11 r=.49). During the first reporting 
period, Master Teams provided an average of 3 (SD=2.45) ICBT sessions per team while Non-
Master Teams provided an average of 1.36 (SD=1.5) ICBT sessions per team demonstrating a 
large effect size (Cohen’s d=.81; r=.37). During the first month, Master Teams provided almost 
double the average number of ICBT sessions (M=3) than non-Master Teams (M= 1.5). However 
this number must be interpreted with caution because 9 of the Master Teams received their initial 
ICBT Training in April and only 3 of the Master Teams received their initial training in May 
while, 4 of the Non-Master Teams received their initial training in April and 7 received their 
initial training in May. Thereby giving the Non-Master Teams more of an opportunity to practice 
ICBT during the first reporting month. By the second reporting month, the average number of 
ICBT sessions was much closer between Master (M=3.5, SD=2.15) and Non-Master Teams 
(M=3.36, SD=2.69) with a very small effect size (Cohen’s d=.06; r=.03). As time went by and 
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supervisory calls took place, Master Teams began to provide a greater average number of ICBT 
sessions than Non-Master Teams (See Table 1). During month 8, when 2 of the 3 Master calls 
took place, Master and Non-Master teams differed the most, with Master Teams providing an 
average of 5.92 (SD=4.99) ICBT sessions and Non-Master Teams providing an average of 2.91 
(SD=3.27) ICBT sessions with a large effect size (Cohen’s d=.71; r=.34). The number of ICBT 
sessions individuals received differed between the Master and Non-Master programs. See Table 
3 below. 
 Table 3. Number of ICBT Sessions Received by Master Status 
Number of Sessions Master Team 
Consumers 
Non-Master Team 
Consumers 
0 8.9% (N=5) 35.7% (N=25) 
1-3 12.5% (N=7) 25.7% (N=18) 
4-7 16.1% (N=9) 14.3% (N=10) 
8-16 39.3% (N=22) 17.1% (N=12) 
17 or More 23.2% (N=13) 7.1% (N=5) 
 
For Master programs, 8.9% (N= 5) of the 56 individuals identified for the study had no 
ICBT sessions; 12.5% (N=7) of individuals had 1-3 ICBT session; 16.1% (N=9) had 4-7 
sessions; 39.3% (N=22) had 8 to 16 sessions; 23.2% (N=13) had 17 or more sessions. For non-
Master programs, 35.7% (N=25) of the 51 identified individuals had no ICBT; 25.7% (18) had 1-
3 sessions; 14.3% (N=10) had 4-7 sessions; 17.1% (N=12) had 8-16 sessions; 7.1% (N=5) had 
17 or more sessions. By the end of the project year, 62.5% of consumers (N= 35) on Master 
teams had the recommended number of ICBT sessions (i.e., 8 or more) ICBT sessions while 
33.4% of consumers (N=17) on Non-Master Teams had 8 or more ICBT sessions. (See Chart 1.) 
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Treatment Outcomes by Master Team Status 
Consumers on Master teams had an average AUS score decrease of .33 points (SD=.42), 
while Non-Master Teams had an average AUS score decrease of .59 (SD=.64) points from the 
first to last period each consumer was in the project. On the DUS, Master teams had an average 
DUS score decrease of .11(SD=.55) points and non-Master Teams also had an overall DUS score 
decrease of .11 points (SD=.56). For Master Teams there was an average PTSD score decrease of 
1.64 (SD=10.44) points and for non-Master Teams there was an average PTSD score decrease 
of .36 points (SD=6.02). For Master Teams, there was an average increase in hospitalizations of 
4% (SD=.25) and ER increase of 6% (SD=.24). For Non-Master Teams there was an average 
decrease in hospitalizations of 8% (SD=.39) and an ER decrease of 10% (SD=.4). See Table 4 
below. 
Table 4. Average Change Scores by Master Status and Sessions by 8 or more and 7 or Less 
(standard deviation in parenthesis) 
  
Average Change Score Master Teams Non-Master Teams 
 
AUS Score Change -.33 (.42) -.59 (-.64) 
DUS Score Change -.11 (.55) -.11 (.56) 
Hospital Change +.04 (.25) -.08 (.39) 
ER Change +.06 (.24) -.1 (.4) 
 
PCL Score Change 
 
-1.64 (10.44) 
 
-.36 (6.02) 
   
Within the Master group, consumers who received an average of 8 or more ICBT 
sessions, the minimum recommended number of sessions, had an average AUS score decrease 
of .35 points (SD=.66) from the time consumers entered and left the project. Within the Non-
Master group, consumers who received an average of 8 or more ICBT sessions had an average 
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AUS score decrease of .76 points (SD=.81). Within the Master group for consumers who 
received an average of 7 or fewer ICBT sessions, there was an average AUS score decrease 
of .23 points (SD=1.1). Within the Non-Master group for consumers who received an average of 
7 or fewer ICBT sessions there was an average AUS score decrease of .59 points (SD=.91). See 
Table 5 below. 
Table 5. Average Change Scores in Points by Master Status and Sessions by 8 or More and 7 or 
Less (standard deviation in parenthesis) 
Average 
Change Score 
 
Master 8 or 
more 
Non-Master 8 or 
more ICBT 
 
Master 7 or less Non-Master 7 or 
less 
AUS Score 
Change 
 
-.35 (.66) -.76 (81) 
 
-.23 (1.1) -.59 (.91) 
DUS Score 
Change 
 
-.14 (.67) .22 (1.3) -.28 1.45) -.12 (.64) 
Hospital 
Change  
 
+.13 (.34) -.1 (.32) -.05 (.61) .03 (.52) 
ER Change 
 
+.16 (.37) 0 -.05 (.61) -.19 (.58) 
PCL Score 
Change 
+.47 (18.77) +.35 (11.37) +.21 (3.91) -.24 (.57) 
 
Within the Master group for consumers who received an average of 8 or more ICBT 
sessions, on average there was a .14 (SD=.67) decrease in DUS score from the time consumers 
entered and left the project. Within the Non-Master group for consumers who received an 
average of 8 or more ICBT sessions there was an average DUS score decrease of .22 points 
(SD=1.3). Within the Master group for consumers who received an average of 7 or fewer ICBT 
sessions, there was an average DUS score decrease of .28 points (SD=1.45). Within the Non-
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Master group for consumers who received an average of 7 or fewer ICBT sessions there was an 
average DUS score decrease of .12 points (SD=.64). See Table 5 above.  
For consumers within the master group who received an average of 8 or more ICBT 
sessions, there was an average PCL score increase of .47 points (SD=18.77) from the time 
consumers entered and left the project. Within the Non-Master group for consumers who 
received an average of 8 or more ICBT sessions there was an average PCL score increase of .35 
points (SD=11.37). Within the Master group for consumers who received an average of 7 or 
fewer ICBT sessions, there was an average PCL score increase of .21 points (SD=3.91). Within 
the Non-Master group for consumers who received an average of 7 or fewer ICBT sessions there 
was an average PCL score decrease of .47 points (SD=.99). These scores must, however, be 
interpreted with caution as only a small percentage of consumers were administered the PCL 
consistently over time and there was some confusion in PCL administration across teams.  
Within the Master group for consumers who received an average of 8 or more ICBT 
sessions, on average there was an average increase of 13%  (SD=.34) in hospitalizations from the 
time consumers entered and left the project and an average increase of 16% in ER visits 
(SD=.37). Within the Non-Master group for consumers who received an average of 8 or more 
ICBT sessions there was a 10% (SD=.32) decrease in hospitalizations on average and no change 
in ER visits. Within the Master group for consumers who received an average of 7 or fewer 
ICBT sessions, on average there was a 5% (SD=.77) decrease in hospitalizations a 5% (SD=.61) 
decrease in ER visits from the time consumers entered and left the project. Within the Non-
Master group for consumers who received an average of 7 or fewer ICBT sessions, there was a 
19% (SD=.58) average decrease in hospitalizations and 24% (SD=.57) decrease in ER visits. 
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Out of the 107 individuals who initially screened positive for PTSD and SUD, 38 of those 
individuals had clinically significant alcohol use as determined by a score of “3” or higher on the 
Alcohol Use Scale among the Master and Non-Master teams. For those 38 individuals, 21 
received 0 to 7 ICBT sessions and had an average decrease of 1 point (range = -3 to 0; SD=1.1) 
on the alcohol use scale. The remaining 17 individuals with an AUS score above a “3” received 8 
or more ICBT sessions and had an average decrease of 1.35 points (range = -3 to 0; SD= 1) on 
the AUS. Thus demonstrating a larger decrease in AUS score for individuals receiving a greater 
amount of ICBT with a medium effect size (Cohen’s d=.33; r=.16). 18 of the 38 individuals with 
AUS scores 3 or higher were on Master Teams and of those 21 individuals 9 received 0 to 7 
ICBT sessions and 12 received 8 or more ICBT sessions. Of those 9 who received 0 to 7 ICBT 
sessions, they had an average AUS score decrease of .56. Of the 9 individuals who took part in 8 
or more ICBT sessions there was an average decrease of 1.22 (-3 to 0; SD=1.09) points.  
Of the 20 individuals who were on Non- Master teams 9 received 0-7 ICBT sessions and 
had an average overall decrease in AUS score of 1.33 (range= -3 to 0; SD= 1.07). Of the 9 Non-
Master Team consumers who received 8 or more ICBT sessions, there was an overall average 
decrease in AUS score of 1.55 points (-3 to 0 SD= .93). The mean AUS score difference between 
Non-Master consumers with AUS scores above 3 who received either 0-7 and 8 or more ICBT 
sessions showed a larger decrease in AUS scores for those individuals receiving 8 or more ICBT 
sessions with a small effect size (Cohen’s d=.22; r=.11). See Table 6 below.  
Table 6. Average Change Scores by Master Status and Sessions by 8 or More and 7 or Less for 
Individuals with Clinically Significant Alcohol Use (standard deviation in parenthesis) 
Average 
Change 
Score 
All Teams 
8 or more 
All Teams 7 or 
less 
 
Master 
Teams 8 or 
more 
Non-
Master 
Teams 8 
or more  
Master 
Teams 0-
7 
Non-
Master 
Teams 0-7 
AUS Score 
Change 
-1.35 (1) -1(1.1) -1.22 (1.09) -1.55 (.93) -.56 -1.33(1.07) 
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Out of the 107 individuals who initially screened positive for PTSD and SUD, 46 of those 
individuals had clinically significant drug use as determined by a score of “3” or higher on the 
Drug Use Scale among the Master and Non-Master teams. For those 46 individuals, 24 
participated in 0-7 ICBT sessions and 22 participated in 8 or more sessions. Of the 24 who 
participated in 0-7 sessions, there was an overall average score increase on the DUS of .5 points 
(range=-3 to 1; SD=1.59). Of the 22 who participated in 8 or more sessions, there was an overall 
DUS score increase of .77 points (range = -3 to 2; SD=1.41). For Master Teams, 11 were 
involved in 0-7 sessions, with an overall DUS score increase of .18 (range=-2 to 4 SD= 1.78) and 
15 were involved in 8 or more visits with an overall DUS score increase of .6 (range=-2 to 3; 
SD=1.4). 13 Non- master team participants had 0-7 sessions, with DUS increase of .77 points 
(range = -1 to 4; SD=1.42). For Non-Master Teams 7 individuals participated in 8 or more ICBT 
sessions with a DUS point increase of 1.14 (range =-1 to 3; SD=1.46). See Table 7 below. 
Table 7. Average Change Scores by Master Status and Sessions by 8 or More and 7 or Less for 
Individuals with Clinically Significant Drug Use (standard deviation in parenthesis) 
Average 
Change 
Score 
All Teams 8 
or more 
All Teams 7 or 
less 
 
Master 
Teams 8 or 
more 
Non-
Master 
Teams 8 or 
more  
Master 
Teams 0-
7 
Non-
Master 
Teams 0-
7 
DUS 
Score 
Change 
+.77 (1.41) +.5 (1.59) +.6 (1.4) +1.14(1.46
) 
+.18 
(1.78) 
+.77 
(1.42) 
 
Supervisory Calls & Fidelity 
 Differences in supervisory call participation and content between Master and Non-Master 
Teams were captured by evaluating the notes taken by the call facilitator from each supervisory 
call. During the calls, teams reported the number of clinicians providing ICBT and number of 
consumers receiving ICBT at the time the calls took place.  In addition, teams were rated on their 
fidelity to the ICBT model on a scale from 1 to 7 with 1 being “not at all;” 4 being “somewhat;” 
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and 7 being “extensively.” Data for 9 of the 12 Master Teams was available for the first 
supervisory call and data for 11 of the 12 Master Teams was available for the second Master call. 
Data for 9 of the 11 Non-Master Teams was available for the first supervisory call and data for 
11 of the 11 Non-Master Teams was available for the second supervisory call.  
 During the first set of supervisory calls, the average number of clinicians providing ICBT 
on each team was 1 (SD =.87) for Master clinicians and 2.33 (SD=2.29) for Non-Master 
Clinicians. During the second call, the number of clinicians providing ICBT on Master teams 
rose 2.18 points to 3.18 clinicians per team (SD=1.89). For non-Master Teams, the number of 
clinicians per team providing ICBT rose .21 points to 2.55 clinicians (SD=1.69).  
 During the first set of calls, the average number of consumers receiving ICBT on each of 
the Master Teams was 1.33 (SD=1.41) while the average number of consumers receiving ICBT 
on the Non-Master Teams was 2.33 (SD=2.24). By the time the second set of calls took place, 
the average number of consumers receiving ICBT on Master Teams rose by 1.49 consumers to 
2.82 consumers (SD=.98). The average number of consumers receiving ICBT Non- Master 
Teams rose by .58 consumers to 2.91consumers (SD=1.64).   
 During the first set of supervisory calls, the average fidelity score for the Master Teams 
was 4.33 (r=1-7, SD=4.23) and the average fidelity score for non-Master Teams was 4 (r=1-7, 
SD=2.5). During the second set of supervisory calls the average fidelity score of Master teams 
decreased by .1 points to 4.23 (r=2-6, SD=1.29). During the second set of supervisory calls, 
average Non-Master Team fidelity rose by .36 points to 4.36 (r=1-7, SD=1.57). 
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Chapter 5: Discussion, Limitations, Study Implications  
Discussion 
Importance of Motivation 
This study demonstrates the benefits and challenges inherent in developing an 
implementation protocol in a community based setting serving individuals with serious mental 
health and co-occurring substance use conditions. The combination of training, phone 
supervision and data collection appeared to create an environment for ACT Teams to try a new 
clinical tool. However, some teams were less eager to provide ICBT than others. Apparent in the 
data and based on observations, teams with motivated leaders and/or members more regularly 
provided ICBT and noted its clinical benefits. While teams who initially felt the ICBT training 
and data collection was a chore that would not benefit the people they serve, were less likely to 
provide ICBT.   
Given the large role motivation appeared to play in the provision of ICBT, it is 
unfortunate that a more formal measure of motivation was not introduced into the study and 
makes interpreting the data quite complex given that those individuals who signed up for Master 
Training appeared more motivated than their counterparts that forwent the additional training 
hours. At the same time, there appears to have been an interactional effect that the Master 
Training plus motivation had on ICBT sessions provided. Specifically, even though Master 
teams were more likely to sign up for additional training, based on the data, it seems as though 
the training also impacted their likelihood of providing ICBT. Similarly, if teams had not been 
offered formal training in ICBT, motivated teams would likely not have started to provide ICBT 
on their own. Thus, pointing to the importance of future research focusing on increasing staff 
motivation in the context of targeted training efforts. Though, perhaps research is warranted in 
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the area of increasing staff motivation alone, to determine if increases in motivation would lead 
individuals or organizations to seek out training in EBPs. 
While staff motivation has been largely discussed in the organizational psychology 
literature (Weiner, 2009), it is only just beginning to become integrated into the concept of EBP 
implementation in mental health settings (Williams et al., 2013). Though implementation 
researchers have addressed motivation in their work (Proctor et al., 2009), more attention to 
motivation and in particular employee values may be worth exploring more when implementing 
a new practice in a behavioral health setting. Specifically, research has shown that individuals 
are the most likely to change when the change aligns with their personal values (Sheldon & 
Kasser, 1998). Furthermore, change is also more likely to take place, when individuals feel 
autonomous and believe that the change behavior is coming from one’s self (Deci & Ryan, 
2000). All of these motivational and change predicting factors appeared relevant to the current 
study despite inclusion of motivation or values based measures.  
In some ways, we did make efforts to determine if specific individual characteristics (e.g. 
age, level of education, years of experience, etc) were relevant to implementation/motivation, 
yet, teams were uncooperative in returning staff demographic questionnaires to us. It is unclear if 
this was due to these questionnaires asking about demographics or related to a more general 
ICBT burnout and ease with which teams could opt out of a voluntary task. Based on 
observation, motivation appeared highest in team members who were new to the field, and just 
starting out in their positions, followed by seasoned team leaders with interest in enhancing their 
teams clinical skills based on their own clinical interests. While it would be unreasonable to 
create a workforce comprised only of certain types of employees, it would be worth exploring 
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how and why some employees are more motivated than others to determine ways to increase 
motivation among individuals with less motivation.  
While the internal staffing patterns of Master and Non-Master teams were similar as a 
result of their being a standard ACT staffing pattern, Master clinicians tended to fall in one of 
two groups. Specifically, Master clinicians tended to be frontline staff at the beginning of their 
careers or seasoned program directors. And in both of these groups, there was a very high level 
of energy and commitment to the individuals they served. This enthusiasm, however, was not 
seem across Non-Master Teams and was also not seen among some of the staff who worked on 
the Master Teams but were not Master clinicians. Thus it appeared that some type of internal 
drivers within the Master clinicians was driving the uptake of ICBT and desire to become Master 
teams. Furthermore, for teams that had enthusiastic leaders (i.e., program directors) the effects 
trickled down to the entire team, thereby allowing for additional ICBT sessions to take place. 
Past data supports the notion that internal clinician characteristics and strong change 
leaders lead to increased treatment uptake (Torrey et al., 2001). In particular and as evidenced in 
this study, team members that believed ICBT would help their clients were more likely to sign 
up for Master training and provide more ICBT sessions. This was contrasted with clinicians and 
team leaders that believe their clients were “too sick” for CBT. Teams that thought they either 
new the CBT model, or didn’t believe the model would work for their clients provided less 
ICBT, were less likely to become Master clinicians and were more likely to submit data late or 
be non-responsive to data coordinator. As is consistent with other research, individuals are much 
more likely to want to learn and implement an evidence based practice if they see it as an area of 
improvement for themselves and as a benefit to their clients (Torrey et al., 2001).  
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The nature of ACT Team work in NYC is another variable that likely influenced 
motivation and commitment to the ICBT model. ACT team work is exceptionally difficult as 
evidenced by staff reports and a very high staff turnover rate. Often for staff who stay on the 
teams and are not promoted to program directors, a sense of bitterness may arise as a result of the 
daily challenges the work imposes with no reward. As a result of this, new staff are often the 
most motivated on ACT Teams. These new staff, tend to fall into three categories; those who 
leave after about one year for a more senior position in another social service sector, those who 
become promoted to a program director on the ACT Team, or those who stay on the team in their 
current role. Those who become promoted or move on, thus appear to be more enthusiastic about 
their work and helping individuals with SMI. In fact, on the Master Teams, two of the Master 
clinicians moved on to higher level positions in different social service sectors before the project 
year ended. These two clinicians, were anecdotally two of the most motivated, and dedicated to 
the ICBT model.  
 Another important factor separating Master and Non-Master Teams apart was the number 
of AOT consumers on their teams. Specifically, Master Teams had fewer AOT consumers than 
Non-Master Teams. Providing care to individuals on AOT proves very challenging as there are 
increased clinical and administrative demands. Clinically individuals on AOT court orders tend 
to be more challenging to engage as they often have AOT orders due to a history of treatment 
non-adherence. Thus, ACT Teams who work with these individuals need to work harder to 
engage these individuals and may feel less satisfied about their work with these individuals do to 
the slow progress and constant engagement techniques they need to employ to ensure these 
consumers see the ACT Teams. Furthermore, AOT court orders require ACT Teams to take 
specific measures to search for AOT consumers when they go missing, something that isn’t rare. 
 49 
These measures, while necessary, burden staff and require specific documentation that takes time 
to complete. Additionally, AOT consumers require additional paperwork overall, and ACT 
Teams often need to help these individuals attend their AOT court dates, which is very time 
consuming for ACT Team workers For teams with additional AOT consumers, the burden of 
added work could make the task of learning and implement a new treatment daunting.  
 The additional work associated with AOT does not fall evenly across ACT Teams and 
may therefore contribute to overall staff bandwidth to do additional work. Staff on ACT Teams 
with additional AOT consumers may become stressed out more easily and feel less engaged in 
their work if they do not have the right support. Given the high intensity of ACT work, AOT 
consumers pose a clinical and administrative challenge for teams that are already overwhelmed. 
Therefore, teams with fewer individuals with AOT court orders are at an advantage in that they 
have less administrative responsibilities and are treating individuals who are less challenging 
clinically. This difference may allow for teams with fewer AOT consumers to feel less 
overwhelmed and motivated about their work, which may explain why teams with fewer AOT 
consumers would sign up for the Master Training.   
While the majority of the data from this study do not isolate benefits of the Master 
training alone, it does highlight the importance of staff motivation and eagerness to gain added 
knowledge in the provision of a new treatment modality. Together, it appears that some 
combination of staff motivation, the Master calls and the earlier supervisory calls lent themselves 
to the provision of ICBT sessions. Staff motivation seems to explain the early differences 
between the Master and Non-Master Teams as well as the Master Teams volunteering for 
additional training. The initial supervisory calls also seem relevant in that ICBT sessions went up 
for both Master and Non-Master teams when ICBT calls took place and seemed to go down as 
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time passed from when the ICBT calls took place. The Master Calls also appear important 
because the data showed that the greatest difference in the number of ICBT session that were 
provided by Master and Non-Master Teams with Master Teams providing more sessions, 
occurred when the Master Calls took place. Thus, it seems these three elements (motivation, 
supervisory calls, and master calls) were important in enabling staff to provide ICBT sessions.  
Much of the observations made in working with the ACT Teams was in line with past 
research independent of progress made by clients and the amount of ICBT provided. 
Specifically, clinicians demonstrated great fears and concerns providing trauma treatments. 
While ICBT is not exposure based and even though clinicians attended ICBT training, many 
were hesitant to practice ICBT because they feared they would retrigger their clients trauma 
histories, which would lead to increased symptomology. Clinicians expressed fears that by 
merely mentioning trauma their clients would become unstable despite evidence discussed 
earlier that points to the contrary. Similarly, even though ICBT is not exposure therapy, because 
ICBT involves trauma, many clinicians did not understand that ICBT did not involve exposure 
despite numerous attempts at education on the supervisory calls and through individual and 
group contact with teams.  
Other clinician fears included a sense that clients were “too sick” to receive ICBT. Many 
clinicians shared that they thought clients with psychosis could not grasp CBT concepts despite 
evidence that suggests otherwise. While the supervisory calls allayed some of these fears, for 
some teams the idea that ICBT was not appropriate for their clients was maintained throughout 
the entire project year despite continuous attempts to explain how ICBT works and its benefits. 
This continued fear or reluctance to use ICBT exemplifies some of the great and many barriers to 
implementing EBPs especially among clinicians who have very strong thoughts and opinions 
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regarding the individuals they serve. Thus, future studies may want to think about, explore and 
address preconceived notions about clients prior to implementing and disseminating and EBP. 
In addition to exploring and addressing preconceived notions about clients upfront, 
evidence suggests that the way an EBP is packaged and sold is very important (Rogers, 2003). 
While attempts were made to package ICBT as user friendly and applicable to ACT clients, 
based on staff fears and concerns regarding ICBT uptake, more marketing could have been done 
early on. By better assessing staff competence and interest in ICBT on a trauma treatment in 
general, the package developed for the ACT Teams could have better sold ICBT. If resistance 
were predicted early on, initial training sessions could have been longer and taken place in 
smaller groups to leave time and space to discuss concerns about ICBT openly thereby assuaging 
fears and motivating staff to use ICBT. 
Another approach to enhancing ACT Team use of ICBT could have been achieved by 
better demonstrating the ease with which ICBT could be implemented in ACT settings. The 
initial ICBT training was given by an ICBT expert with little ACT Team knowledge. While the 
initial training explained ICBT well it neglected to demonstrate the ease with which it could be 
used on ACT Teams. According to Rogers (2003), the easier an innovation appears to be, the 
more likely it will be used. An adapted version of the initial ICBT training was offered to new 
staff at several points during the study year and the new training was specifically tailored to ACT 
Teams. These trainings received more positive reviews of ICBT and several of the staff who 
attended these trainings went on to become Master clinicians. As a result of adapting the training 
by focusing specifically on ICBT for ACT and demonstrating its applicability and ease of use, 
there were more favorable results.  
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In addition to adapting the marketing and training for this study, it was apparent that 
strong change leaders were pivotal in the implementation of ICBT. As has been found in the 
research having change leaders who are interested and excited about an EBP strongly predicts 
implementation outcomes (Aarons et al., 2012; McGovern, Lambert-Harris, McHugo, Giard & 
Mangrum, 2010; Torrey et al., 2011; Sylvain & Lamothe, 2013). In this study, teams that had 
eager Team Leaders and involved management provided ICBT more regularly and were more 
likely to volunteer for the Master training. Unfortunately, however, in addition to strong change 
leaders financial support also often helps with EBP implementation – and none of our teams 
received additional financial support to implement ICBT. 
Despite the lack of financial support or incentives, as expected teams did respond well to 
supervision, especially those teams that had strong change leaders and motivated staff. While 
this study did not include a measure of motivation, past research shows supervision is 
particularly meaningful within the context of agency buy-in and workflow changes (Brunette et 
al., 2008; Rapp, Goscha, & Carlson, 2010). The importance of this combination was apparent for 
our teams though difficult to reflect in the data. Based on observations of teams, it was clear that 
supervision was the most meaningful to motivated teams that were willing to change their 
workflow to incorporate ICBT. Again speaking to the importance of motivation in dissemination 
and implementation initiatives. 
While it may be assumed that teams with greater fidelity to the ICBT model would be 
more motivated provide more ICBT sessions, this did not seem to be the case. Despite the greater 
number of ICBT sessions provided by Master Teams, initial fidelity to the ICBT model was 
similar for Master and Non-Master Teams. Fidelity was measured by the ICBT supervisory call 
facilitator who was the same across all calls. Based on her ratings, during the initial two 
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supervisory calls Master and Non-Master Teams demonstrated a similar fidelity to the model, 
thereby indicating that early on ICBT sessions quality was likely similar across the two groups. 
This shows that while, Master Teams provided more ICBT sessions it was not the result of better 
understanding the ICBT model, but again perhaps was the result of motivation to provide the 
actual sessions. Given the addition of the Master calls for Master Teams and added information 
learned, over time Master Teams may have increased fidelity to the ICBT model but because we 
did not track fidelity over time this information is unknown.  
Fidelity to the model is an interesting concept to think about in this study as it seemed 
that fidelity was mostly based on past the training experiences teams had and not motivation or 
other factors. The initial training and supervisory calls did appear to be uniformly helpful across 
the Master and Non-Master Teams and past CBT experience seemed related to fidelity on 
supervisory calls. However, familiarity with CBT did not seem related to interest in Master 
training or implementation as is consistent with the notion that uptake of a treatment model is 
more likely to take place when clinicians see a need for a particular training (Torrey et al., 2001).  
It’s also perhaps true that as Master Teams learned the model in more and more depth, 
they became better at integrating ICBT into their usual practice and not documenting their work 
as strictly ICBT.  This may explain why ICBT sessions began to decline after the three Master 
calls took place.  However, it may also be true that on-going supervision is needed regularly and 
continuously for a treatment to be used consistently. While, there were some short-term benefits 
in the provision of ICBT sessions during period 8, when two ICBT Master Calls took place, they 
were not sustained overtime and other factors or ways to increase implementation need to be 
identified. Perhaps, one way to do this is to work with clinicians to show a continued need to 
practice and enhance learning around the specific therapy technique that one is looking to 
 54 
implement. Again, this points to a need for a more nuanced understanding of motivation in 
implementation and dissemination research.   
Successes and Failures of Master Training 
Despite concerns regarding motivation, burnout and overall workload, ACT Teams 
provided a lot of ICBT and clinicians reported thinking about and approaching the individuals 
they serve differently. While there were some teams that provided very little ICBT, maintained a 
non-recovery stance (e.g., stating that individuals on ACT Teams were “too sick for CBT”) and 
lacked interest in the treatment, a considerable number of teams made real changes in the way 
they provided assessments and treatment. Individual clinicians shared success stories and were 
appreciative of learning this treatment, reporting that they had been improving their relationships 
with their clients through engaging them in a structured treatment. Interestingly, teams reported 
that even though at times, AUS, DUS, and Stage of Change scores weren’t changing, they 
observed clients becoming more open to treatment, more reflective of their situations, and better 
able to regulate emotions. While the study did not capture these outcomes, they are important 
considerations for ACT Teams in that engagement is reported as a large challenge facing these 
teams. Providing a treatment that allows clients to better relate and interact with staff not only 
helps them move toward recovery but makes clinicians like their jobs better.  
In this study, Master Teams provided a greater number of ICBT sessions compared to 
Non-Master Teams overall and throughout the project year. Again, there is a clear element of 
motivation associated with the Master Teams’ performance, however, the Master calls 
themselves appeared to influence the amount of ICBT provided by the Master Teams. This was 
seen when looking at the data, which showed that during the months Master calls took place, 
more ICBT sessions were provided. In fact, on average Master Teams provided the most ICBT 
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sessions during the month that the first two Master calls took place. During this month, Master 
teams and Non-Master teams also had the greatest difference in terms of ICBT sessions 
provided, with Master Teams providing more ICBT sessions than Non-Master Teams. This large 
difference demonstrates the importance of ongoing support once a training has taken place in 
addition to highlighting how without regular ongoing support the effects of training are 
diminished. Despite, Master Teams continuing to provide more ICBT sessions on average than 
Non-Master Teams for the remainder of the project year, the amount of ICBT provided by them 
was the most when they had two support calls in one single month. 
 Given that Master Teams were self-selected, there is still question as to whether or not 
Master Teams were more likely to provide more ICBT sessions independent of the Master 
Training. At first glance Master Teams appeared to have an advantage from the start in that they 
provided a greater number of ICBT sessions on average during the first reporting period when 
compared to Non-Master Teams. While this data make it appear as though Master Teams had an 
advantage early on, differences in the provision of ICBT sessions may have been attributed to a 
greater number of Master than Non-Master Teams being introduced to ICBT during the first part 
of the reporting period.  
Due to training and time constraints, not all Teams were trained the same day and by 
what appears to have been chance, most of the teams that later volunteered to be Master Teams 
were trained during the first training sections that took place two weeks before the second set of 
training sections. This difference in training dates gave those teams trained earlier more exposure 
to ICBT early on and a greater chance to provide ICBT during the first reporting period. This 
difference in training date may thus explain why during the second reporting period Master and 
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Non-Master Teams provided similar amounts of ICBT. And thus give added support to the idea 
that on going supervisory support aids in the provision of an EBP after training.  
In some ways, it is interesting that Master Teams tended to receive their initial ICBT 
training early on and points to the importance of ensuring initial training sessions are equivalent 
in this type of work. For instance, during the early training dates there were more DOHMH staff 
present at the trainings, which might have influenced the atmosphere of the training. DOHMH 
staff may have led the trainer to perform better or for teams to pay more attention and in turn 
learn more about the treatment. If teams learned more about ICBT because the trainer did a 
better job or because they paid more attention, they may have been more interested in further 
education because they would have been better able to see the benefits ICBT would have on their 
work. Based on observation, it seems more likely that teams were more influenced by staff 
presence than the trainer, though the theory that the better teams understood ICBT the more they 
would want to further their understanding holds. Specifically, it seems likely that teams who 
were trained in the presence of DOHMH staff who oversaw their programs would have paid 
more attention in the training sessions.  
 Once all teams were trained, by the second reporting period, Master and Non-Master 
Teams seemed to be providing similar amounts of ICBT. Arguably, this time would be a better 
base from which Master and Non-Master Teams could be compared. As time went on, however, 
Master Teams began to provide a greater number of ICBT sessions on average – even prior to 
the start of the Master Training. The greater ICBT uptake seen by Master Teams again, was 
likely related to motivation and perhaps a greater openness to ICBT supervisory calls. The idea 
of their being an interactional effect wherein motivation combined with other factors such as the 
initial supervisory calls would lead to greater amounts of ICBT seemed apparent here. 
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Considering that Master Teams self-selected to receive additional training, it makes sense that 
they would be more responsive to ICBT supervisory calls and more interested in providing 
ICBT.  
Master Teams may have started out more strongly than Non-Master Teams based on the 
initial training date, however, this does not explain the reason that Master Teams started to 
perform better in terms of ICBT sessions provided prior to the Master calls taking place. 
Perhaps, one possibility for the greater number of ICBT sessions provided by Master Teams after 
period two and prior to the Master calls may be that Master Teams responded better to the initial 
supervisory calls and thus were more likely to sign-up for the Master calls as a result. Similarly, 
another possibility is that Master Teams may have been more inclined to want to impress the 
trainers on their first set of supervisory calls, thereby providing more ICBT sessions as a result of 
the supervisory calls taking place. In this way, these teams who later selected themselves to 
become Master Teams may have not only been motivated to learn ICBT because of personal 
and/or professional interest but perhaps out of a sense of obligation or desire to perform well. 
Anecdotally, it is also true that the teams that volunteered to be Master Teams, were more likely 
to submit their data on time and were more responsive to the principal investigator generally. 
This seems inline with organizational psychology research, which points to agreeableness as a 
trait related to performance and uptake of a new practice or tool (Devaraj, Easley, & Crant, 2008 
& Longwe, Lord & Carrillo, 2015). 
Despite speculation that Master teams may have been more responsive to supervisory 
calls or particularly interested in impressing supervisory call facilitators, when looking at data 
from the calls themselves, Non-Master Teams actually appeared to report higher rates of ICBT 
fidelity and more clinicians providing ICBT than Master Teams. This finding is surprising in that 
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one would think teams that later became Master trained would be more eager and open to 
providing ICBT in an adherent way early on. It is possible that Non-Master teams were actually 
those that learned and understood the model better and were thus less interested in further ICBT 
training.  
The most striking difference in ICBT sessions between Master and Non-Master Teams 
took place during the eighth reporting period when the first two Master calls took place. During 
period 8 on average Master Teams provided more ICBT sessions than Non-Master Teams. The 
increased difference in ICBT sessions provided by Master teams during period 8 seems to 
indicate that the 2 Master calls that took place during that reporting period may have led to an 
increase in ICBT sessions for Master Teams. Furthermore, it seems as though having scheduled 
two supervisory calls in close proximity to one and other was particularly helpful as indicated by 
a decrease in ICBT sessions for Master Teams during period 9 when only one Master call took 
place.  
Even though ICBT sessions decreased on average during period 9 for Master Teams, 
ICBT sessions also decreased on average during period 9 for Non-Master Teams. ICBT sessions 
dropped again during period 10 when there were no longer any Master Calls taking place and as 
the project year was ending. The increase in ICBT sessions during period 8, thus indicates some 
benefit to having calls in close proximity to one and other. At the same time, having a Master 
call during period 9 may have been an added benefit in that Master Teams continued to provide 
more ICBT sessions on average than Non-Master Teams. An interesting finding, however, was 
seen during the last reporting period when the difference in average ICBT sessions provided by 
Master and Non-Master Teams decreased. During the last reporting period, average ICBT 
sessions decreased for Master Teams but increased for Non-Master Teams. Perhaps Non-Master 
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teams decided to try harder as the project year came to a close given that many of the Non-
Master Teams did not provide ICBT on a regular basis. For Master Teams it is unclear why 
average ICBT sessions dropped, but the drop was so minimal that it likely indicated sessions 
were starting to plateau.  
Disappointingly and an apparent failure of the Master Training, was seen in the clinical 
outcomes associated with Master Teams versus Non-Master Teams. Consumer drug, alcohol, 
stage of change, PTSD, ER and hospital outcomes for Master and Non-Master Teams varied 
between teams. For individuals with alcohol use above a score of 3 on the AUS at the start of 
their time in the project, Non-Master team consumers had greater decreases in alcohol use than 
Master Team consumers overall. This was also true of all consumers on average, not just those 
with scores of 3 or higher on the AUS.  
For consumers on Master and Non-Master teams, individuals who received more ICBT 
sessions also had greater AUS score decrease. This finding was expected, but again, on average, 
Non-Master Teams performed better than Master Teams in terms of AUS score decreases when 
more sessions were provided, which was not expected. This finding suggests that there was 
perhaps some added benefit to the type of ICBT or other additional substance use treatment 
provided by Non-Master Teams. These findings put into question the value of the Master calls on 
the quality of the ICBT provided. While, greater numbers of ICBT sessions were associated with 
better AUS score outcomes, these associations favored Non-Master Teams. At the same time, 
because more sessions meant better outcomes, the value of the Master calls cannot be entirely 
negated based on this finding in that Master Teams did provide more ICBT sessions on average.  
What is somewhat discrepant from the anticipated hypothesis is that AUS scores seemed 
to go down more for consumers on Non-Master Teams. While it was expected that Master 
 60 
Teams would have better treatment outcomes, for alcohol use, this was not the case. It is possible 
that Non-Master teams were better versed in providing substance use treatment, which may 
explain why they did not volunteer for additional training. Or perhaps, because Master teams 
received more training, they may have been assessing for alcohol use more accurately. Another 
possibility is that is Master teams were focusing on trauma more than Non-Master teams, alcohol 
use, though part of ICBT may have received less attention than Non-Master Teams that may 
have focused primarily on substance use.  
ICBT Impact  
The data collected as it related to consumer outcomes was mixed, which may have been 
the result of the data we collected, the mechanisms by which we collected the data, the treatment 
itself or some combination. One standard observation made in the data was that greater decreases 
in alcohol use were seen for consumers with more significant AUS scores. This makes sense in 
that higher AUS scores likely led clinicians to focus more on alcohol use and given the higher 
scores there was more room for those scores to go down. For consumers with AUS scores of 1, 
or 2, AUS scores may not have needed to go down in that scores of 1 and 2 indicate no clinical 
problem with alcohol use. This is important to consider in that it points to perhaps a greater 
utility of ICBT use for individuals with more severe substance use needs.  
Despite AUS score decreases for individuals on Master and Non-Master Teams, DUS 
score decreases were very slight from the start to end of the project year. Even more surprisingly, 
when looking at DUS scores, fewer ICBT sessions appeared to be associated with better DUS 
score outcomes. Outcomes looked best for consumers on Master Teams who received 7 or fewer 
ICBT sessions. This finding does not seem to make sense given that we expected both alcohol 
and drug use scores to go down. When only looking at individuals with clinically significant 
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DUS Scores (3 or higher), the picture becomes even more complicated. For individuals receiving 
7 or fewer ICBT sessions or those receiving 8 or more, DUS scores increased. This was also true 
regardless of whether consumers were on Master or Non-Master Teams, with average DUS 
scores going up regardless of Master status.  
DUS score changes overtime in the two groups was in contrast to what was expected to 
happen for individuals receiving ICBT or in the study in general. It was expected that DUS 
scores would go down overtime with AUS scores and as treatment progressed. Perhaps as 
individuals decreased alcohol use or addressed PTSD symptoms, increases in drug use followed 
to help individuals cope with increased anxiety. However, we do not have the necessary data to 
determine why these increases in DUS scores were found. Research does not suggest that as one 
substance decreases another arises and research has shown that as PTSD symptoms subside 
substance use will subsequently be reduces (Hien et al., 2009).  
One challenge faced as part of this study was the lack of attention to PTSD symptom 
assessment by all teams. And therefore, this did not allow for their to be an exploration of 
whether the reduction of PTSD symptoms led to subsequent substance decreases or increases 
given how the data looked. While teams were regularly encouraged to administer the PCL, the 
length of the instrument appeared to impede teams from regularly assessing PTSD symptoms. 
Despite monthly prompting, most teams sporadically assessed for PTSD using the PCL, and 
therefore PTSD scores were not captured regularly. As such, the PTSD data collected appears to 
be somewhat unreliable.  
It is unfortunately not surprising that ACT Teams did not regularly administer the PCL 
given that many teams did not want to be treating trauma and since the PCL requires more time 
than the AUS and DUS. If teams felt more comfortable with trauma treatment and also had more 
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time for assessment, the results here may have looked different. As a result of team’s trepidation 
to talk about trauma, it is perhaps likely that trauma treatment was not at the forefront of teams’ 
minds and perhaps led to such varied average substance use outcomes. If teams were more 
comfortable discussing trauma and implementing CBT techniques to reduce PTSD symptoms, 
drug use may have been impacted more positively. Anecdotally, for some teams, particularly 
some Master Teams, those that were more open to assessing and talking about trauma reported 
better consumer outcomes. Again, however, this was not captured in the summary data, which 
included both Master and Non-Master Teams that expressed reluctance to address trauma. 
Hospital and ER data in this study were also difficult to analyze in that average changes 
in hospital and ER data were minuscule across time. The only group that demonstrated an 
average decrease in hospitalizations was for Non-Master Teams that provided 8 or more ICBT 
sessions. However, the decrease was very small and during that same period ER visits did not 
change for this group. One challenge to the way this data were collected was that I only asked 
teams to report whether or not a consumer went to the hospital or ER for psychiatric reasons 
each month. Despite wanting to capture multiple hospitalizations and ER visits in a month, 
DOHMH staff who oversee ACT Teams were concerned about not wanting to overburden ACT 
Team members and asked for me to capture the data in this way. At the same time, and a positive 
thing, it did not seem as though many ICBT consumers were going to the hospital, which 
demonstrates the benefits of the ACT Team work as a whole.  
The uneven outcomes across Master and Non-Master Teams when assessed comparing 
teams that provided 8 or more or 7 or fewer ICBT sessions does not paint a clear picture of the 
benefits associated with ICBT. While individuals in the groups receiving 8 or more ICBT 
sessions seemed to make greater improvements across some domains, these benefits were not 
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uniform nor were there uniform differences between Master and Non-Master data. These 
findings point to the great difficulties inherent in bringing EBPs into real world settings. While 
teams seemed to receive sufficient training up front, fidelity was not captured over time nor were 
there standardized fidelity checks, which makes analyzing outcome data even more complicated 
in that there is no way to find out if what ACT Teams were reported as ICBT sessions were in 
fact true ICBT sessions. 
EBP Limitations 
 As mentioned in the literature review, some clinicians lack confidence in EBPs as they 
are conflated with ESTs and clinicians question manualized treatments and the RCTs that 
support their efficacy and effectiveness. While ICBT is a manualized treatment made up of 
several EBPs, its effectiveness once removed from a controlled study is subject to critique. 
Anecdotally ICBT clinicians reported that ICBT helped consumers become more engaged and 
allowed for greater therapeutic work, however, the data here is not overwhelmingly supportive of 
the treatment as compared to treatment as usual. Thus, it is worth thinking about what it means to 
bring an EBP or EST into a non-controlled setting, arguments against EBP and EST language 
and the notions of common factors related to good therapeutic interventions. 
 It is reasonable to assume that the clinicians trained in this study did not receive the same 
extensive type of treatment or fidelity check as those who were in studies that gave credence to 
ICBT’s effectiveness. While all ACT Team members received a one full day of training in ICBT, 
this training was not specifically created for ACT Teams and the work they do. Thus, attention 
was likely lost in these training settings, as was evidenced by one staff member who was actually 
observed going in and out of sleep. These trainings were also large and as such did not allow 
much time for personalization or checks to ensure staff understood the content. Furthermore, 
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apart from observational data related to fidelity on the supervisory calls, this study lacked 
adequate fidelity checks and as such the quality of the ICBT is to be questioned here. While 
these flaws may have led to an adulterated version of ICBT, they are important to consider in 
that this study likely emulates real world adoption of EBPs or ESTs and points to the difficulties 
inherent in implementing an EBP. No matter how good a treatment is, there is no guarantee 
outside of taped therapy sessions to ensure adherence to the model – something that would be 
very difficult for community providers to adopt across all clinicians in a community mental 
health setting.  
 Once an EBP is taken out of a controlled research setting, much can go awry and speaks 
to concerns that prominent psychologists have regarding the emphasis on EBPs and EBP/EST 
language (Wachtel, 2010). Requirements for treatments to be manualized and funding only being 
given to groups practicing EBPs, is thus flawed. Specifically, EBP language and rhetoric 
assumes that if one is using CBT, for example, they are practicing an ideal treatment, however, 
CBT means many things, and without proper supervision and adherence that which the clinician 
is practicing may as well be treatment as usually. Consider, on the other hand, a clinician not 
practicing and EBP per se, but a clinician with many years of experience and knowledge of many 
effective practices that he/she has learned from research, supervisors and individual cases – it is 
likely that this individual is providing care that is relevant, meaningful and leads to positive 
outcomes. However, because this individual isn’t practicing an EBP or EST as we know of them 
(i.e., a specific treatment), their work may be subject to scrutiny by insurers and/or oversight 
entities if not documented correctly. 
 Another pitfall of EBPs that may have impacted this work is related to the “common 
factors” associated with beneficial psychotherapy. These factors include empathy, the alliance, 
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therapist positive regard and genuineness (Norcross, 2011). While these factors encompass the 
spirit of ICBT and these factors were discussed in our trainings, they weren’t done so 
systematically and more focus and attention was placed on the treatment itself. While teaching 
common factors takes place in graduate schools and intensive psychotherapy training, they are 
not easy to teach in a time limited training even with supervision especially when the focus is on 
a specific treatment modality. Thus, in this way, the effects of ICBT may have been impeded 
somehow by the lack of focus on common factors. And since we did not control for these factors, 
we cannot determine their impact on the results.  
Limitations 
This study had a number of limitations. The greatest limitation was that the study did not 
control for any of the extraneous variables that set the Master and Non-Master Teams apart. 
While the basic composition of most teams was known, individual provider variables were not 
known or explored. Despite trying to survey Teams to better understand specific individual 
provider variables, most Teams did not respond to this request. This request was made at the end 
of the project year at which time most teams were tired of submitting data. This lack of 
responsiveness was another limitation to the study overall, as most of the ACT Teams are very 
busy and feel overworked thereby making requests for data or ability to engage in activities that 
are in addition to the ACT model very challenging. However, even if we had more specific 
details, past research shows that individual provider variable including work experience are not 
particularly relevant to EBP adoption (Lindholm, Koivukangas, Lassila & Kampman 2015). 
Another limitation of this study was the variability across and within teams in terms of 
PCL administration. Early on some teams were identified as administering the PCL incorrectly, 
and while this was addressed – on average, most teams did not regularly administer the PCL. 
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Similarly, AUS and DUS scores were not reported by the same clinician necessarily each month, 
which brings into question the validity of these scores. It is possible that some clinicians would 
rate consumers differently based on their individual relationships with the consumers. With this, 
also comes the concern that Non-Master Teams may have been reporting consumer outcomes 
more positively than was the case to better represent themselves. While this is also possible for 
Master Teams, given that Master Teams appeared more conscientious and agreeable than Non-
Master Teams, it is possible that Master Teams were more likely to report themselves accurately 
because of their proclivity to follow the rules.  
The most glaring limitation of this study was that teams self-selected into the Master 
group. Thus, the impact of the Master calls could not be isolated due to this self-selection bias. 
Thus, it is unclear how much if at all the Master calls increased the use of ICBT or whether self-
selected teams were innately more motivated to provide ICBT. Furthermore, factors such as staff 
motivation, sense of obligation or stage in one’s career could have greater predictor’s of self-
selection and ICBT use. Individuals who participated in the Master training appeared more 
motivated and responsive to the project coordinator than clinicians who did not receive the 
Master training. At the same time there were large differences in the amount of ICBT provided 
by Master and Non-Master Teams that do not seem to have only been explained by motivation. 
Instead, it appears that staff motivation had some type of additive effect on ICBT sessions 
provided when paired with the additional training. However, since our groups were self-selected 
and motivation was not formally assessed, there is no way to determine if there was in fact an 
additive effect of combining training with motivation.  
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Study Implications and Significance 
 While the data from this study are limited in many ways, the study has indicated the 
importance of staff motivation on training outcomes and the role in which supervisory calls post-
training can add to treatment implementation. Even though Master Teams received more 
training, their treatment implementation outcomes seem influenced by treatment team members 
motivation. However, it does seem as though the additional training did provide a booster to 
Master Teams. Furthermore, given that most implementation studies do not include client level 
data and this one did, the impact of training on client outcomes seems minimal while the 
provision of added ICBT seems somewhat beneficial for alcohol and PTSD score.  
An additional finding of this study that may impact future work with ACT Teams is the 
evidence that teams who volunteered for advanced training had fewer AOT clients. This finding 
implies that there may be a benefit to ensuring AOT consumers are more equally distributed 
across teams and/or fewer consumers are served by teams with these consumers. AOT 
consumers pose a large administrative and clinical time addition to ACT Team therapists. This 
study, thus demonstrates how that time addition can decrease motivation for additional training. 
If teams have more administrative and clinical tasks, it may help the system to equally distribute 
ACT consumers across teams city-wide.  
AOT appeared to be one element of this work that was ICBT prohibitive, however, more 
broadly, clinician uptake of ICBT really demonstrated the difficulties inherent in bringing EBPs 
to real world settings. While the study findings were mixed, teams regularly complained about 
providing ICBT, thought their consumers were too sick for ICBT and did not want to collect 
consumer level data despite benefits to patients. This reality demonstrates the ways in which 
patience and attention are extremely important in implementing EBPs in real world settings. 
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Even though the study results were mixed, in the end many clinicians and consumers were 
exposed to ICBT, which was the result of the training, on-going data collection and supervisory 
calls. This exposure to ICBT likely had greater impact on the clinicians and consumers than this 
study could demonstrate. However, it was clear in working with clinicians that continued support 
around data collection and reminders of supervisory calls was pivotal in helping teams provide 
ICBT.  
Finally and perhaps most importantly, this work shows how difficult it is to successfully 
implement an EBP training protocol in a real world behavioral health setting. Future work needs 
to enlist support of teams and staff early on and before training to build motivation, understand 
values related to treatment and find ways to easily and seamlessly incorporate a new practice into 
an ongoing treatment setting. While, this study was able to accomplish getting a number of ACT 
Team members interested in and using ICBT, many staff members felt resentful about the 
implementation protocol and did not want to learn or provide ICBT. This study shows that while 
efforts were made to keep ACT Teams in mind and work with them in a supportive way, that 
motivation really needs to be better enhanced and understood to successfully implement EBPs.   
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Chapter 6: Study Summary 
Study Summary 
This study examined the impact of added supervision on trauma training outcomes 
among ACT Teams. While it was expected that teams receiving increased supervision would 
provide ICBT more frequently and have better consumer outcomes, the results were mixed. 
Overall, Master Teams did provide more ICBT sessions than Non-Master Teams however, 
consumer outcomes were not always better for Master Teams and the extent to which the 
supervisory calls impacted ICBT sessions provided is still unclear. What this study did seem to 
demonstrate was the importance of staff motivation on training participation and treatment 
implementation. In addition, the study hinted to the possible benefits of finding ways to increase 
staff motivation through training in conjunction with added supervision and ICBT training.  
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